cholestyramine resin has been researched along with Hypercholesterolemia in 360 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 216 (60.00) | 18.7374 |
| 1990's | 112 (31.11) | 18.2507 |
| 2000's | 25 (6.94) | 29.6817 |
| 2010's | 5 (1.39) | 24.3611 |
| 2020's | 2 (0.56) | 2.80 |
| Authors | Studies |
|---|---|
| Hernán, MA; Madenci, AL; Murray, EJ; Wanis, KN | 1 |
| Alder, M; Bavishi, A; Peterson, J; Stone, NJ; Zumpf, K | 1 |
| Adewole, EK; Dada, AO; Farombi, EO; Mokobia, OE; Nwichi, SO; Ogidiama, O | 1 |
| Anzivino, C; Bertolotti, M; Carulli, L; Carulli, N; Corna, F; Del Puppo, M; Gabbi, C; Kienle, MG; Loria, P; Pellegrini, E; Ricchi, M; Zambianchi, L | 1 |
| Achem, J; Adaramoye, OA; Akintayo, O; Fafunso, MA | 1 |
| Chapman, MH; Chiu, MC; Kahlon, TS | 1 |
| Jokubaitis, LA | 2 |
| Cipollone, F; Faggin, E; Ganassin, L; Grego, F; Mezzetti, A; Pauletto, P; Plebani, M; Puato, M; Rattazzi, M; Zambon, A | 1 |
| Gupta, A; Guyomard, V; Myint, PK; Rehman, HU; Zaman, MJ | 1 |
| Gasbarrini, A; Gasbarrini, G; Pizzoferrato, M; Ponziani, FR; Scaldaferri, F | 1 |
| Aoki, I; Bakalova, R; Hadjidekov, G; Ishii, I; Kitada, M; Saga, T; Tomizawa, A; Zhelev, Z | 1 |
| Gylling, H; Miettinen, TA | 1 |
| Dick, JB; Patterson, D; Struthers, AD | 1 |
| Gylling, H; Miettinen, TA; Vanhanen, H | 1 |
| Coello-Ramírez, P; González-Ortiz, M; Larrosa-Haro, A; Sáenz-Rivera, C; Vázquez-Camacho, G | 1 |
| Bouzamondo, A; Corvol, JC; Hulot, JS; Lechat, P; Sanchez, P; Sirol, M | 1 |
| Nagai, Y; Yamashita, S | 1 |
| CRAMPTON, RS; HASHIM, SA; TENNENT, DM; VAN ITALLIE, TB | 1 |
| TENNENT, DM; ZANETTI, ME | 1 |
| DATTA, DV; SHERLOCK, S | 1 |
| GHERONDACHE, CN; PINCUS, G | 1 |
| HASHIM, SA; VANITALLIE, TB | 1 |
| KLION, FM; LATUFF, AJ; SCHAFFNER, F | 1 |
| Kane, JP; Malloy, MJ; Pullinger, CR | 1 |
| Borghi, C; Dormi, A; Gaddi, A; Sangiorgi, Z; Veronesi, M | 1 |
| Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM | 1 |
| Charlotte, N; Sani, M | 1 |
| Ballantyne, CM; Chitra, R; Miller, E | 1 |
| Plans-Rubió, P | 1 |
| Egashira, Y; Hayakawa, K; Sanada, H; Shibata, S | 1 |
| Achem, J; Adaramoye, OA; Akintayo, OO; Fafunso, MA | 1 |
| Cai, Z; Kuroki, M; Pearl, J; Tian, J | 1 |
| Casdorph, HR | 3 |
| Vachon, JM | 1 |
| Bateson, MC | 1 |
| Schwartz, MZ | 1 |
| Kostner, G; Lithell, H; Thomis, J; Vessby, B | 1 |
| Miettinen, TA | 7 |
| Alberts, AW; Chao, Y; Yamin, TT | 1 |
| Spengel, FA; Thompson, GR | 1 |
| Alberts, AW; Chao, YS; Yamin, TT | 1 |
| Stamler, J | 1 |
| Aldrich, RF; Battaglini, JW; Brensike, JF; Epstein, SE; Kelsey, SF; Levy, RI; Loh, IK; Passamani, ER; Richardson, JM; Stone, NJ | 1 |
| Kolata, G | 1 |
| Rifkind, BM | 3 |
| Oliver, MF | 1 |
| Janus, ED; Nye, ER; Scott, PJ | 1 |
| Nestel, PJ | 1 |
| Lacombe, C; Nibbelink, M | 1 |
| Glueck, CJ | 1 |
| Farinaro, E; Mancini, M; Montefusco, S; Postiglione, A | 1 |
| Johnstone, JR | 1 |
| Katan, MB | 1 |
| Canzler, H | 1 |
| Faruqui, AM; Thurmond, MS; Wenger, J; Wenger, NK | 1 |
| Kane, JP; Malloy, MJ | 2 |
| Fears, R; Ferres, H; Richards, DH | 1 |
| Boyden, TW; Totman, L | 1 |
| Bard, JM; Dallongeville, J; Duriez, P; Fruchart, JC; Hagen, E; Ose, L; Pfister, P | 2 |
| Jacob, BG; Richter, WO; Schwandt, P | 1 |
| Banga, JD; Jacotot, B; Peters, TK; Waite, R | 1 |
| Bergmann, SD; Haggerty, BJ; Winick, AG; Zavoral, JH | 1 |
| Peters, TK | 1 |
| Bergstrand, L; Elinder, LS; Erikson, U; Holme, I; Johansson, J; Mölgaard, J; Nilsson, S; Olsson, AG; Walldius, G | 1 |
| Elinder, LS; Hådell, K; Holme, I; Johansson, J; Mølgaard, J; Olsson, AG; Walldius, G | 1 |
| Ginsberg, HN | 1 |
| Brazg, R; Maciejko, JJ; Patil, S; Rubenfire, M; Shah, A | 1 |
| Anderson, TJ; Frei, B; Ganz, P; Meredith, IT; Selwyn, AP; Yeung, AC | 1 |
| Denke, MA | 1 |
| Denke, MA; Grundy, SM | 1 |
| Wennmalm, A | 1 |
| Chin, JP; Dart, AM | 1 |
| Cigolini, M; Graziani, MS; Grigolini, L; Muggeo, M; Sartori, A; Travia, D; Trimeloni, S; Zenti, MG | 1 |
| Almon, L; Fletcher, BJ; Fletcher, GF; Staggers, J; Whitner, JT | 1 |
| Gordon, MO; Schechtman, KB | 1 |
| Bard, JM; Bodd, E; Borge, M; Eriksen, HM; Fruchart, JC; Hagen, E; Istad, H; Ose, L; Selvig, V; Wolf, MC | 1 |
| Bergstrand, L; Erikson, U; Hådell, K; Johansson, J; Kaijser, L; Lassvik, C; Mölgaard, J; Nilsson, S; Olsson, AG; Walldius, G | 1 |
| Rosenberg, R | 1 |
| Garg, A; Grundy, SM | 1 |
| Abrams, J; Allen, JW; Chrysant, SG; Fischer, JJ; Ginsberg, H; Johnson, BF; Jokubaitis, L; Keane, WF; Sprecher, DL; Theroux, P | 1 |
| Lau, CP; Leung, WH; Wong, CK | 1 |
| Abolafia, JM; Davis, CE; Jenner, JL; Lamon-Fava, S; Levy, RI; Lippel, K; McNamara, JR; Ordovas, JM; Schaefer, EJ | 1 |
| Kolesár, P | 1 |
| Hwang, DS; Jokubaitis, LA; Robinson, WT; Smith, HT; Troendle, AJ | 1 |
| McKenney, JM | 1 |
| Davidson, C; Davidson, D; Iversen, SA | 1 |
| Erkelens, DW; Portincasa, P; Renooij, W; Smit, JW; Van Berge-Henegouwen, GP; Van Erpecum, KJ | 1 |
| Hahn, C; Reichel, C; von Bergmann, K | 1 |
| Grundy, SM; Vega, GL | 1 |
| Daggy, BP; Dietschy, JM; Turley, SD | 1 |
| Gibaldi, M; Kradjan, W | 1 |
| Richter, WO | 1 |
| Aranda, JL; del Palacio, A; Jover, E; Nogués, X; Rubiés-Prat, J | 1 |
| Kamata, K; Kasuya, Y; Suenaga, H; Sugiura, M | 1 |
| Dotti, MT; Federico, A; Lindenthal, B; Lütjohann, D; Simatupang, A; von Bergmann, K | 1 |
| Aznar Lucea, J; Blesa Baviera, LC; Dalmau Serra, J; Martínez Silvestre, M; Vayá Montaña, A | 1 |
| Cullen-Dean, G; Helden, E; McCrindle, BW; O'Neill, MB | 1 |
| Farmer, JA; Gotto, AM | 1 |
| Hidaka, H; Kashiwagi, A; Kawabata, T; Kikkawa, R; Kojima, H; Konaka, K; Nakamura, T; Shigeta, Y | 1 |
| Corrigan, F | 1 |
| Carrilho, AJ; Medina, WL; Nakandakare, ER; Quintão, EC | 1 |
| Ito, MK; Shabetai, R | 1 |
| Kesten, S; Maurer, J; Mayne, L; Scavuzzo, M | 1 |
| Collins, SM; Gaw, A; Lindsay, GM; Lorimer, AR; Packard, CJ; Shepherd, J | 1 |
| Celermajer, DS; Simons, J; Simons, LA; Sullivan, D | 1 |
| Eriksson, M; Hådell, K; Holme, I; Kjellström, T; Walldius, G | 1 |
| Simons, LA | 1 |
| Goldberg, DJ; Nicolosi, RJ; Rogers, EJ; Sacchiero, R; Wilson, TA | 1 |
| Scheen, AJ | 1 |
| Gordon, BR; Saal, SD | 1 |
| Oster, G; Thompson, D | 1 |
| Hjalte, K; Lindgren, B; Persson, U | 1 |
| Gonzalez, ER | 1 |
| Benesch, L; Bestehorn, HP; Betz, P; Blümchen, G; Böcker, JF; Braunagel, K; Claus, J; Kappenberger, L; Kiefer, H; Leimenstoll, B; Mathes, P; Meister, G; Neiss, A; Peters, K; Petersen, J; Rensing, UF; Roskamm, H; Samek, L; Schemeitat, K; Schuon, J; Spinder, M; Stiepel, E; Wieland, H | 1 |
| Agrawal, R; Arntz, HR; Fischer, F; Linderer, T; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W | 1 |
| Barter, PJ; O'Brien, RC | 1 |
| Calara, F; de Nigris, F; Napoli, C; Palinski, W; Witztum, JL | 1 |
| Chin-Dusting, JP; Shaw, JA | 1 |
| Abe, M; Aihara, K; Akaike, M; Azuma, H; Ikeda, Y; Matsumoto, T; Sugihara, T | 1 |
| Brown, WV | 1 |
| Casanada, F; Condorelli, M; D'Armiento, FP; de Nigris, F; Napoli, C; Palinski, W; Silvestre, M; Witztum, JL | 1 |
| Steinmetz, KL | 1 |
| Bersohn, I; Dinner, M; Heimann, KW; Mieny, C; Pettifor, J; Saaron, I; Spitz, L; Stein, EA | 1 |
| Farah, JR; Kwiterovich, PO; Neill, CA | 2 |
| Lloyd, JK; West, R | 1 |
| Brannan, PG; Brown, MS; Goldstein, JL | 1 |
| Lloyd, JK | 1 |
| Harry, DS; McIntyre, N; Pearson, AJ | 1 |
| Rider, AK | 1 |
| Carlson, LA; Olsson, AG; Orö, L; Rössner, S | 3 |
| Blum, CB; Havlik, RJ; Morganroth, J | 1 |
| Fisher, WR; Truitt, DH | 1 |
| Simons, LA; Williams, PF | 1 |
| Einarsson, K; Hellström, K | 1 |
| Harding, PA; Mann, JI; Turner, RC; Wilkinson, RH | 1 |
| Dairou, F; Olsson, AG | 1 |
| Lempinen, M; Miettinen, TA | 1 |
| Lloyd, JK; West, RJ | 2 |
| Grundy, SM | 3 |
| Dijkhuis-Stoffelsma, R; Fernandes, J; Grose, WF | 1 |
| Lehtonen, A; Viikari, J | 1 |
| Diament, J; Forti, N; Giannini, SD | 1 |
| Howard, AN | 1 |
| Martz, BL | 1 |
| Kissebah, AH | 1 |
| MacSween, RN; Mills, PR; Rooney, PJ; Watkinson, G | 1 |
| Castrillo, JM; Díaz-Curiel, M; Rapado, A | 1 |
| Roncari, DA | 1 |
| Campanari, JC; Forti, NA; Giannini, SD; Timoner, M | 1 |
| Hagihira, H; Kashu, T; Nakabou, Y; Takano, Y | 1 |
| Heuck, CC; Mordasini, R; Oster, P; Raetzer, H; Schellenberg, B; Schlierf, G; Twelsick, F | 1 |
| Cocuzza, E; Conti, F; De Simone, R; Lovati, MR; Sirtori, CR; Sirtori, M | 1 |
| Jacotot, B | 1 |
| Blanckaert, D; Farriaux, JP | 1 |
| Burns, MJ; Hoff, EJ; Smith, EF | 1 |
| Fallat, RW; Glueck, CJ; Mellies, M; Tsang, RC | 1 |
| Adams, PW; Moutafis, CD; Myant, NB; Simons, LA; Wynn, V | 1 |
| Kim, DN; Lee, KT; Li, JR; Reiner, JM; Rogers, DH; Thomas, WA | 1 |
| Albertini, F | 1 |
| Fallat, RW; Glueck, CJ; Mellies, MJ; Tsang, RC | 1 |
| Huttunen, J | 1 |
| Brunner, G | 1 |
| Hanson, RF; Isenberg, JN; Page, AR; Sharp, HL; Williams, GC; Zavoral, J | 1 |
| Lanner, A; Miettinen, TA; Nikkila, EA | 1 |
| Fosbrooke, AS; Lloyd, JK; West, RJ | 1 |
| Pain, RW | 1 |
| Bassett, DR; Hough, JC | 1 |
| Tierney, E | 1 |
| Kim, DN; Lee, KT; Reiner, JM; Thomas, WA | 2 |
| Rossini, L | 1 |
| Ebeling, T; Happonen, P; Miettinen, TA; Pyörälä, K; Turtola, H; Uusitupa, MI; Voutilainen, E | 1 |
| Granegger, S; O'Grady, J; Pesau, B; Pirich, C; Schmid, P; Sinzinger, H; Virgolini, I | 1 |
| Clifton, P; Janus, ED; Nestel, PJ; Parfitt, A; Simons, J; Simons, LA | 1 |
| Alessandri, C; Peverini, F | 1 |
| Ose, L | 1 |
| Jacob, BG; Möhrle, W; Richter, WO; Schwandt, P | 1 |
| Freedman, LS; Graubard, BI; Schatzkin, A | 1 |
| Hibbard, DM; Hoogwerf, BJ; Hunninghake, DB | 1 |
| Aviram, M; Brook, GJ; Hoffman, R | 1 |
| Ebeling, T; Pyörälä, K; Reijonen, T; Turtola, H; Uusitupa, M; Voutilainen, E | 1 |
| Caslake, MJ; Gaw, A; Griffin, BA; Packard, CJ; Shepherd, J; Yip, B | 1 |
| Ebeling, T; Happonen, P; Parviainen, M; Pyörälä, K; Turtola, H; Uusitupa, M; Voutilainen, E | 1 |
| Courtney, SP; Wightman, JA | 1 |
| Lundh, BL; Mölgaard, J; Olsson, AG; von Schenck, H | 1 |
| Bobbio, M; Brusca, A | 1 |
| Gallagher, JJ; Maher, VM; Myant, NB; Thompson, GR | 1 |
| Liu, K | 1 |
| Dammann, HG; Ditschuneit, H; Ditschuneit, HH; Dreyer, M | 1 |
| Kuijpens, JL; Martens, LL; Rutten, FF; Winter, J | 1 |
| Bertomeu, A; Casals, E; Cusó, E; Ros, E; Sanllehy, C; Zambón, D | 1 |
| Insull, W; Marquis, NR; Tsianco, MC | 1 |
| Ito, MK; Morreale, AP | 1 |
| Ansoleaga, J; Joven, J; Masana, L; Vilella, E | 1 |
| Howard, PA | 1 |
| Bo, M; Fabris, F; Fiandra, U; Pedrazzini, V; Pernigotti, L; Poli, L; Zanocchi, M | 1 |
| Bard, JM; Douste-Blazy, P; Fruchart, JC; Parra, HJ | 1 |
| Maher, VM; Thompson, GR | 1 |
| Brescia, D; DeVault, AR; Ivashkiv, E; Pan, HY; Swites, BJ; Whigan, D; Willard, DA | 1 |
| Eisenberg, JM; Glick, H; Jacobson, TA; Kinosian, B; Koffer, H; Schulman, KA; Willian, MK | 1 |
| Bimmermann, A; Schleicher, J; Schwartzkopff, W | 1 |
| Acosta, AM; Arteaga, A; Maíz, A; Velasco, N; Villanueva, CL | 1 |
| Ast, M; Frishman, WH | 1 |
| Shapiro, DR; Walker, JF | 1 |
| Bergmann, S; Fischer, S; Fücker, K; Gehrisch, S; Hanefeld, M; Jaross, W; Lang, PD; Leonhardt, W | 1 |
| Clifton, P; Cooper, ME; Jennings, GL; Jerums, G; Nestel, PJ; O'Brien, RC; Simons, LA; Sullivan, D | 1 |
| Belamarich, PF; Deckelbaum, RJ; Dobrin, BE; Salen, G; Starc, TJ; Tint, GS | 1 |
| Chistiakova, AM; Frolova, IuV; Khanefel'd, M; Leonkhardt, V; Lozovskiĭ, VT; Remezova, OV; Ryzhenkov, VE; Solov'eva, MA; Triufanov, VF; Vasil'eva, LE | 1 |
| Laupacis, A; Roberts, RS; Sackett, DL | 1 |
| Diamond, JR; Hanchak, NA; Karnovsky, MJ; McCarter, MD | 1 |
| Cattin, L; Da Col, PG; Fonda, M; Mazzone, C; Pertot, P | 1 |
| Carlson, LA; Nilsson, J; Regnström, J; Walldius, G | 1 |
| Imaizumi, K; Lu, YF; Murakami, J; Sugano, M | 1 |
| Day, CE | 1 |
| Kreisberg, R; Mantell, G; Miller, V; Shapiro, DR; Stein, E; Washington, L | 1 |
| Mölgaard, J; Olsson, AG; von Schenck, H | 1 |
| Breslow, JL; Eisenberg, S; Weintraub, MS | 1 |
| Stoy, DB | 1 |
| Caslake, MJ; Cruickshank, A; Demant, T; Kilday, C; Lorimer, AR; Packard, CJ; Series, JJ; Shepherd, J | 1 |
| Lintott, CJ; Nye, ER; Robertson, MC; Scott, RS; Sutherland, WH | 1 |
| Nordøy, A; Ytre-Arne, K | 1 |
| Rywik, S | 1 |
| Gohlke, H | 1 |
| Deslypere, JP | 1 |
| Turpin, G | 1 |
| Goldstein, MR | 1 |
| Swindell, AC; Valentine, JJ | 1 |
| Brensike, J; Detre, KM; Kelsey, SF; Krauss, RM; Levy, RI; Lindgren, FT; Vranizan, K; Williams, PT | 1 |
| Mol, MJ; Stalenhoef, AF; Stuyt, PM | 1 |
| Greten, H; Windler, E | 1 |
| Anding, RH; Lueg, MC | 1 |
| Epstein, AM; Oster, G | 1 |
| Eisenberg, JM; Kinosian, BP | 1 |
| Carlson, LA; Erikson, U; Johansson, J; Kaijser, L; Lassvik, C; Mölgaard, J; Nilsson, S; Olsson, AG; Stenport, G; Walldius, G | 1 |
| Tyroler, HA | 1 |
| Holler, HD; Lang, PD; Müller, S; Steinhagen-Thiessen, E | 1 |
| Ekelund, LG; Gordon, DJ; Hannan, PJ; Hyde, J; Jacobs, DR; Trost, DC; Whaley, FS | 1 |
| Duane, WC; Freeman, ML; Gebhard, RL; Hunninghake, DB; Prigge, WF | 1 |
| Bruno, M; Di Perri, T; Franchi, M | 1 |
| Bell, SM; Tishler, PV; Winston, SH | 1 |
| Nikkilä, EA; Tikkanen, MJ | 1 |
| Havel, RJ; Kane, JP | 1 |
| Davis, CE; Glueck, CJ; Gordon, DJ; Nelson, JJ; Tyroler, HA | 1 |
| Gordon, DJ; Knoke, J; Probstfield, JL; Superko, R; Tyroler, HA | 1 |
| Crouse, JR | 1 |
| Bailey, KR; Brewer, HB; Hoeg, JM; Maher, MB | 1 |
| Stuyt, PM | 1 |
| Widhalm, K | 1 |
| Donkerlo, TW | 1 |
| DiPalma, JR | 1 |
| Corraze, G; Lacombe, C; Nibbelink, M | 1 |
| Bonfiglioli, D; Branchi, A; Cabrini, E; Pogliaghi, I; Sommariva, D; Tirrito, M | 1 |
| Kronmal, RA | 1 |
| Pollak, OJ | 1 |
| Gotto, AM | 1 |
| Pepper, GA | 1 |
| Hackley, JJ; Hassan, AS; Johnson, LL | 1 |
| Beynen, AC; De Bruijne, JJ; Katan, MB | 1 |
| Ducimetière, P | 1 |
| Chase, HP; Porter, KA; Putnam, CW; Starzl, TE | 1 |
| Levy, RI; Mitchell, S | 1 |
| Billimoria, JD; Fahmy, MF; Jepson, EM; Maclagan, NF; Torrens, PE | 1 |
| Bricker, LA | 1 |
| Khachadurian, AK; Uthman, SM | 1 |
| Hrubá, F; Pechar, J; Válek, J | 1 |
| Balfour, JF; Kim, R | 1 |
| Kuo, PT | 1 |
| Bersohn, I; Mendelsohn, D; Stein, EA | 1 |
| Fallat, RW; Glueck, CJ; Scheel, D; Tsang, RC | 1 |
| Baggio, G; Baiocchi, MR; Briani, G; Crepaldi, G; Fellin, R | 1 |
| Fallat, RW; Glueck, CJ; Tsang, R | 1 |
| Gotto, AM; Levy, RI; McMahon, AE; Morganroth, J | 1 |
| Albrink, MJ | 2 |
| Fallat, RW; Glueck, CJ; Mellies, M; Tsang, R | 1 |
| Bybee, DE; Hamilton, RD | 1 |
| Fallat, RW; Glueck, CJ; Tsang, RC | 1 |
| Jain, A; Ryan, JR | 1 |
| Edwards, IR; Frenk, E; Walker, AE | 1 |
| Beaumont, JL; Beaumont, V; Buxtorf, JC; Jacotot, B; Le Parco, JC | 1 |
| Berkowitz, D | 1 |
| Bilheimer, DW; Brown, WV; Fredrickson, DS; Glueck, CJ; Gotto, AM; Herbert, PN; Kwiterovich, PO; Langer, T; LaRosa, J; Levy, RI; Lux, SE; Rider, AK; Shulman, RS; Sloan, HR; Stone, NJ | 1 |
| Bagdade, JD | 1 |
| Evans, RJ; Howard, AN; Hyams, DE | 2 |
| Danzinger, RG; Hofmann, AF | 1 |
| Evans, C; Howard, AN; Hyams, DE | 1 |
| Fumagalli, R; Paoletti, R; Sirtori, R | 1 |
| Bavina, MV; Koropova, GI; Lobova, NM; Perova, NV | 1 |
| Faergeman, O | 1 |
| Connor, WE | 1 |
| Parker, F; Short, JM | 1 |
| Howard, AN; Hyams, DE | 1 |
| Langer, T; Levy, RI | 1 |
| Gresham, GA; Howard, AN | 1 |
| Butts, WH; Scott, HW; Younger, RK | 1 |
| Butts, WH; Scott, HW; Shepard, GH; Younger, RK | 1 |
| Likoff, W | 1 |
| Ahrens, EH; Grundy, SM; Nestel, PJ; Salen, G; Schreibman, PH | 1 |
| Kaffarnik, H; Schneider, J | 2 |
| Spector, AA | 1 |
| Weizel, A | 1 |
| Garcia, MJ; Kannel, WB; McNamara, PM; Pearson, G | 1 |
| Lewis, B | 1 |
| Myant, NB | 1 |
| Ostrander, LD | 1 |
| Moutafis, CD; Myant, NB | 1 |
| Pometta, D | 1 |
| Adamson, G; Strisower, B; Strisower, EH | 1 |
| Maha, GE | 1 |
| Rowe, GG | 1 |
| Buckwald, H; Frantz, ID; Lee, GB; Moore, RB; Varco, RL | 1 |
| Crane, CA; Frantz, ID; Moore, RB | 1 |
| Sanbar, SS; Smet, G | 1 |
| Fallon, HJ; Woods, JW | 1 |
| Kahlke, W; Schlierf, G | 1 |
| Hamlin, JT | 1 |
| Barrillon, A; Binet, JP; de Gennes, JL; Hazan, E; Lenègre, J | 1 |
| Fredrickson, DS | 1 |
| Roe, DA | 1 |
50 review(s) available for cholestyramine resin and Hypercholesterolemia
| Article | Year |
|---|---|
A Meta-Analysis Assessing Additional LDL-C Reduction from Addition of a Bile Acid Sequestrant to Statin Therapy.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Colesevelam Hydrochloride; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Treatment Outcome | 2020 |
Systematic review on evidence of the effectiveness of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Coronary Disease; Drug Therapy, Combination; Evidence-Based Practice; Ezetimibe; Fatty Acids, Omega-3; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Patient Selection; Phytosterols; Practice Guidelines as Topic; Primary Prevention; Risk Assessment; Risk Factors; Risk Reduction Behavior; Secondary Prevention; Treatment Outcome | 2010 |
Use and indications of cholestyramine and bile acid sequestrants.
Topics: Anticholesteremic Agents; Bile; Cholestasis; Cholestyramine Resin; Humans; Hypercholesterolemia; Sequestering Agents | 2013 |
[Combination therapy of hypercholesterolemia].
Topics: Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Margarine; Phytosterols | 2002 |
Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
Topics: Anticholesteremic Agents; Atorvastatin; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Regression Analysis; Risk Assessment; Risk Factors; Simvastatin; Stroke; Treatment Failure; Treatment Outcome | 2003 |
[Treatment of high blood cholesterol in patients with coronary heart disease].
Topics: Anion Exchange Resins; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Primary Prevention; Probucol; Receptors, LDL; Risk Factors | 2003 |
Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.
Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Diet, Fat-Restricted; Ezetimibe; Genetic Predisposition to Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Receptors, LDL | 2003 |
Effects of hypolipidemic drugs on bile acid metabolism in man.
Topics: Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fiber; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Neomycin; Nicotinic Acids; Plants, Medicinal; Sterols; Thyroxine | 1981 |
Receptor-mediated low-density lipoprotein catabolism.
Topics: Cholestyramine Resin; Fibroblasts; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Lipoproteins, LDL; Receptors, Cell Surface; Receptors, LDL | 1982 |
Relationship of hypercholesterolemia in rabbits to lipoprotein binding receptors on liver membranes.
Topics: Animals; Cholesterol, Dietary; Cholestyramine Resin; Hypercholesterolemia; Liver; Rabbits; Receptors, Cell Surface; Receptors, Lipoprotein | 1983 |
Treatment of hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine | 1982 |
Update on the treatment of hypercholesterolemia, with a focus on HMG-CoA reductase inhibitors and combination regimens.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Coronary Disease; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Niacin | 1995 |
Nitric oxide (NO) in the cardiovascular system: role in atherosclerosis and hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Blood Vessels; Cardiovascular Physiological Phenomena; Cholestyramine Resin; Endothelium, Vascular; Humans; Hypercholesterolemia; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Rabbits; Vasodilation; Vasodilator Agents | 1994 |
Treating elevated cholesterol levels: the great Satan in perspective.
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Health Policy; Humans; Hypercholesterolemia; Risk Factors; United States | 1996 |
Fluvastatin in combination with other lipid-lowering agents.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic | 1996 |
Choosing the right lipid-regulating agent. A guide to selection.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Fenofibrate; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hypolipidemic Agents; Niacin; Triglycerides | 1996 |
Cost-effectiveness of drug therapy for hypercholesterolaemia: a review of the literature.
Topics: Age Factors; Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Lovastatin; Risk Factors; Sex Factors; Treatment Outcome | 1992 |
The pharmacoeconomic benefits of cholesterol reduction.
Topics: Cholestyramine Resin; Coronary Disease; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Health Care Costs; Hospitalization; Humans; Hypercholesterolemia; Risk Factors; United States | 1998 |
Lipids and atherosclerosis: clinical management of hypercholesterolaemia.
Topics: Arteriosclerosis; Cholestyramine Resin; Clinical Trials as Topic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipid Metabolism; Niacin; Nutritional Physiological Phenomena; Probucol | 2001 |
Therapies on the horizon for cholesterol reduction.
Topics: Acetamides; Acetates; Anticholesteremic Agents; Azetidines; Carrier Proteins; Cholestyramine Resin; Ezetimibe; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hydroxysteroid Dehydrogenases; Hypercholesterolemia; Membrane Glycoproteins; Pyrimidines; Rosuvastatin Calcium; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids | 2001 |
Colesevelam hydrochloride.
Topics: Allylamine; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hypolipidemic Agents | 2002 |
Hyperlipidaemia in children.
Topics: Adolescent; Age Factors; Child; Child, Preschool; Cholestasis; Cholesterol; Cholestyramine Resin; Chylomicrons; Coronary Disease; Diabetes Complications; Electrophoresis; Fasting; Glycogen Storage Disease; Glycogen Storage Disease Type I; Humans; Hypercholesterolemia; Hyperlipidemias; Hypothyroidism; Infant; Lipoproteins; Liver Diseases; Nephrotic Syndrome; Puberty; Triglycerides; Xanthomatosis | 1975 |
The hypercholesterolaemia of obstructive jaundice.
Topics: Animals; Bile Ducts; Cholestasis; Cholesterol; Cholestyramine Resin; Clofibrate; Electrophoresis, Polyacrylamide Gel; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lipoproteins, VLDL; Liver; Liver Cirrhosis, Biliary; Phosphatidylcholine-Sterol O-Acyltransferase; Phosphatidylcholines; Phospholipids; Plasmapheresis; Protein Binding; Xanthomatosis | 1975 |
The common hyperlipoproteinemias: an understanding of disease mechanisms and their control.
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Ethanol; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoprotein Lipase; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Phenotype; Triglycerides | 1976 |
Bile acid metabolism in hyperlipoproteinaemia.
Topics: Bile Acids and Salts; Cholelithiasis; Cholesterol; Cholestyramine Resin; Cholic Acids; Chylomicrons; Clofibrate; Homeostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids; Triglycerides; Xanthomatosis | 1977 |
Treatment of hypercholesterolemia.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Coronary Disease; Diet, Reducing; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Nicotinic Acids; Triglycerides | 1977 |
[Therapeutic orientation in the hyperlipidemias].
Topics: Cholestyramine Resin; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Neomycin; Nicotinic Acids; Oxandrolone; Probucol; Sitosterols; Triglycerides | 1979 |
[Clinical evaluation of a selective inhibitor of cholesterol synthesis: pravastatin].
Topics: Adult; Animals; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Guinea Pigs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Pravastatin; Rats; Risk Factors; Simvastatin; Time Factors | 1992 |
[Advance in drug treatment of primary and familial hypercholesterolemia].
Topics: Animals; Cholestyramine Resin; Drugs, Chinese Herbal; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Panax; Plants, Medicinal; Probucol | 1991 |
Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Cost-Benefit Analysis; Drug Therapy, Combination; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Niacin; Probucol; Sensitivity and Specificity | 1990 |
Bile acid sequestrants.
Topics: Chemical Phenomena; Chemistry; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lipoproteins, VLDL; Polyamines; Resins, Plant | 1990 |
[Significance of hypercholesterolemia for epidemiology, prevention and pathogenesis of coronary heart diseases].
Topics: Arteriosclerosis; Cholesterol; Cholestyramine Resin; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Sex Factors | 1989 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Risk | 1987 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
A clinical approach to the hyperlipidemias.
Topics: Aluminum; Carcinoma, Hepatocellular; Cholestasis; Cholestyramine Resin; Dextrothyroxine; Diabetes Complications; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Eye Diseases; Fats, Unsaturated; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Liver Neoplasms; Myxedema; Nephrotic Syndrome; Nicotinic Acids; Triglycerides; Xanthomatosis | 1971 |
Dietary and drug treatment of primary hyperlipoproteinemia.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinic Acids; Phospholipids; Thyroxine; Triglycerides | 1972 |
Hypercholesterolemia and hypertriglyceridemia in children. A pediatric approach to primary atherosclerosis prevention.
Topics: Arteriosclerosis; Cardiovascular Diseases; Child; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Economics; Fats; Fatty Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Triglycerides | 1974 |
Dietary and drug treatment of hyperlipidemia in diabetes.
Topics: Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholestyramine Resin; Clofibrate; Diabetes Mellitus; Diabetic Angiopathies; Dietary Carbohydrates; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Nicotinic Acids; Thyroxine; Triglycerides | 1974 |
Familial and acquired hyperlipoproteinemias in children and adolescents.
Topics: Adolescent; Adult; Blood Protein Disorders; Child; Cholesterol; Cholestyramine Resin; Diet, Atherogenic; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Lipoproteins; Lipoproteins, LDL; Middle Aged; Pedigree; Triglycerides | 1974 |
The primary hyperlipoproteinemias.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins; Lipoproteins, LDL; Nicotinic Acids; Thyroxine; Triglycerides | 1974 |
Therapeutics XIX. Lipid lowering agents.
Topics: Animals; Arteriosclerosis; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Metabolism; Lipoproteins; Metabolic Diseases; Nicotinic Acids; Triglycerides; Xanthomatosis | 1972 |
Treatment of hypercholesterolemia by interference with bile acid metabolism.
Topics: Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Hypercholesterolemia; Ileum; Ligation; Liver Circulation; Time Factors | 1972 |
Management of the hyperlipidemic patient.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Estrogens; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism, Inborn Errors; Lipids; Metabolism, Inborn Errors; Nicotinic Acids; Triglycerides | 1973 |
Therapy of the hyperlipoproteinemias.
Topics: Cholestyramine Resin; Clofibrate; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Phenformin; Triglycerides | 1972 |
Current views on cholesterol metabolism.
Topics: Adipose Tissue; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Dietary Fats; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Intestinal Mucosa; Liver; Obesity; Sterols | 1974 |
Measures to reduce the serum lipid levels in coronary heart disease.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholesterol; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Fats; Estrogens; Humans; Hypercholesterolemia; Lipids; Middle Aged; Neomycin; Nicotinic Acids; Sterols | 1968 |
Xanthomatosis associated with hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Chylomicrons; Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Norethindrone; Propionates; Thyroxine; Triglycerides; Xanthomatosis | 1970 |
Hypolipidemic drugs and hyperlipoproteinemia.
Topics: Blood Protein Disorders; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Humans; Hypercholesterolemia; Lipoproteins; Models, Biological; Nicotinic Acids; Thyroxine; Triglycerides | 1971 |
Dietary aspects of atheroslcerosis and thrombosis.
Topics: Animals; Arachis; Arteriosclerosis; Butter; Cholesterol; Cholestyramine Resin; Coronary Disease; Depression, Chemical; Diet; Diet, Atherogenic; Dietary Fats; Fatty Acids, Essential; Glycine max; Haplorhini; Humans; Hypercholesterolemia; Lipids; Medicago sativa; Rabbits; Rats; Thrombosis; Triglycerides; Zea mays | 1968 |
101 trial(s) available for cholestyramine resin and Hypercholesterolemia
| Article | Year |
|---|---|
Fluvastatin in combination with other lipid-lowering agents.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic | 1994 |
Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Atherosclerosis; Atorvastatin; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Cholestyramine Resin; Endarterectomy, Carotid; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lymphocyte Count; Macrophages; Male; Pyrroles; Sitosterols | 2010 |
Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Cholesterol, LDL; Cholestyramine Resin; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Male; Middle Aged; Prospective Studies; Simvastatin | 2004 |
Efficacy and safety of rosuvastatin alone and in combination with cholestyramine in patients with severe hypercholesterolemia: a randomized, open-label, multicenter trial.
Topics: Aged; Aged, 80 and over; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides | 2004 |
Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins; Apolipoproteins B; Cholestyramine Resin; Dose-Response Relationship, Drug; Female; Humans; Hypercholesterolemia; Lipoprotein(a); Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged | 1982 |
Pharmacological trials: primary and secondary prevention of coronary heart disease.
Topics: Aspirin; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dipyridamole; Estrogens; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Sulfinpyrazone | 1983 |
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Triglycerides | 1984 |
The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Mortality | 1984 |
The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Male | 1984 |
Lowered cholesterol decreases heart disease.
Topics: Adult; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clinical Trials as Topic; Double-Blind Method; Heart Diseases; Humans; Hypercholesterolemia; Male; Middle Aged; Risk | 1984 |
Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Topics: Adult; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Random Allocation | 1984 |
Lipid Research Clinics Program.
Topics: Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 1984 |
Hypercholesterolaemia and coronary heart disease: an answer.
Topics: Adult; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged | 1984 |
Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Apolipoproteins; Apolipoproteins A; Apolipoproteins C; Apolipoproteins E; Bile Acids and Salts; Cholestyramine Resin; Double-Blind Method; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipoproteins; Male; Middle Aged; Triglycerides | 1995 |
Long-term efficacy with fluvastatin as monotherapy and combined with cholestyramine (a 156-week multicenter study). French-Dutch Fluvastatin Study Group.
Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Cohort Studies; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Safety; Triglycerides | 1995 |
Efficacy of fluvastatin, a totally synthetic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. FLUENT Study Group. Fluvastatin Long-Term Extension Trial.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Longitudinal Studies; Male; Safety | 1995 |
Changes in plasma apolipoprotein B-containing lipoparticle levels following therapy with fluvastatin and cholestyramine. European Fluvastatin Study Group.
Topics: Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein C-III; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Male; Middle Aged; Risk Factors; Triglycerides | 1995 |
Fluvastatin in severe hypercholesterolemia: analysis of a clinical trial database.
Topics: Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Indoles; Information Systems; Longitudinal Studies; Male; Middle Aged; Placebos; Risk Factors; Triglycerides | 1995 |
Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report.
Topics: Apolipoprotein A-I; Arteriosclerosis; Cholesterol, HDL; Cholestyramine Resin; Female; Femoral Artery; Humans; Hypercholesterolemia; Male; Middle Aged; Probucol; Radiography; Regression Analysis; Sweden | 1995 |
Probucol treatment decreases serum concentrations of diet-derived antioxidants.
Topics: Antioxidants; Cholestyramine Resin; Diet; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Patient Compliance; Probucol; Regression Analysis; Sweden | 1995 |
Psyllium for the reduction of cholestyramine-associated gastrointestinal symptoms in the treatment of primary hypercholesterolemia.
Topics: Abdominal Pain; Adult; Aged; Analysis of Variance; Cholestyramine Resin; Constipation; Diarrhea; Double-Blind Method; Female; Flatulence; Gastrointestinal Diseases; Heartburn; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Psyllium | 1994 |
The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
Topics: Acetylcholine; Anticholesteremic Agents; Antioxidants; Cholestyramine Resin; Coronary Artery Disease; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Probucol; Regression Analysis; Vasoconstriction; Vasodilation | 1995 |
Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia.
Topics: Adult; Aged; Cholesterol, Dietary; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Sitosterols | 1995 |
Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Severity of Illness Index; Treatment Outcome | 1995 |
HBPRCA Astra Award. Therapeutic restoration of endothelial function in hypercholesterolaemic subjects: effect of fish oils.
Topics: Acetylcholine; Adult; Australia; Awards and Prizes; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Endothelium, Vascular; Female; Fish Oils; Forearm; Humans; Hypercholesterolemia; Hypertension; Lovastatin; Male; Middle Aged; Regional Blood Flow; Simvastatin | 1994 |
Effects of variable doses and formulations of cholestyramine on elevated serum low-density lipoprotein cholesterol.
Topics: Adult; Aged; Cholesterol, LDL; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Middle Aged; Powders; Prospective Studies; Tablets | 1995 |
Fluvastatin efficacy and tolerability in comparison and in combination with cholestyramine.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Diet; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Lipids; Patient Compliance | 1994 |
The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST).
Topics: Arteriosclerosis; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Female; Femoral Artery; Humans; Hypercholesterolemia; Image Processing, Computer-Assisted; Male; Middle Aged; Probucol; Radiography | 1994 |
Cholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trial.
Topics: Adult; Aged; Cholesterol, LDL; Cholestyramine Resin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Risk Factors | 1994 |
Low-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patients.
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hypercholesterolemia; Indoles; Male; Middle Aged; Patient Compliance; Single-Blind Method; Triglycerides | 1994 |
Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Aged; Case-Control Studies; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Lipids; Lipoprotein(a); Logistic Models; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Risk Factors | 1994 |
Pharmacokinetics of fluvastatin and specific drug interactions.
Topics: Adolescent; Adult; Aged; Aging; Biological Availability; Cholestyramine Resin; Diet; Digoxin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lipoproteins, LDL; Male; Middle Aged; Niacin; Propranolol; Sex Characteristics; Time Factors; Triglycerides | 1993 |
Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Topics: Adult; Aged; Alanine Transaminase; Aspartate Aminotransferases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Creatine Kinase; Double-Blind Method; Drug Combinations; Female; Humans; Hypercholesterolemia; Liver; Male; Middle Aged; Placebos; Pravastatin; Safety; Triglycerides | 1993 |
The acceptability of resin therapy to patients attending a hospital lipid clinic.
Topics: Adolescent; Adult; Aged; Anion Exchange Resins; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Cross-Over Studies; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Inpatients; Male; Middle Aged; Surveys and Questionnaires | 1995 |
Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
Topics: Anticholesteremic Agents; Bile; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Gallbladder; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Prospective Studies; Simvastatin; Ultrasonography | 1995 |
Hypercholesterolemia with cholesterol-enriched LDL and normal levels of LDL-apolipoprotein B. Effects of the step I diet and bile acid sequestrants on the cholesterol content of LDL.
Topics: Aged; Anticholesteremic Agents; Apolipoproteins B; Base Sequence; Cholesterol; Cholestyramine Resin; Diet, Fat-Restricted; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Molecular Probes; Molecular Sequence Data; Polymerase Chain Reaction; Reference Values; Single-Blind Method | 1996 |
Fluvastatin in combination with other lipid-lowering agents.
Topics: Anticholesteremic Agents; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hypercholesterolemia; Hypolipidemic Agents; Indoles; Niacin; Randomized Controlled Trials as Topic | 1996 |
[Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lovastatin; Male; Middle Aged; Triglycerides | 1996 |
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
Topics: Adult; Aged; Anticholesteremic Agents; Anticoagulants; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Artery Bypass; Coronary Artery Disease; Coronary Thrombosis; Drug Therapy, Combination; Female; Graft Occlusion, Vascular; Humans; Hypercholesterolemia; Life Tables; Lovastatin; Male; Middle Aged; Saphenous Vein; Treatment Outcome; Warfarin | 1997 |
Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial.
Topics: Adolescent; Anticholesteremic Agents; Attitude to Health; Child; Cholestyramine Resin; Cross-Over Studies; Female; Humans; Hypercholesterolemia; Lipids; Male; Patient Acceptance of Health Care; Patient Compliance; Powders; Tablets; Time Factors | 1997 |
Pravastatin alone and in combination with low-dose cholestyramine in patients with primary hypercholesterolemia and coronary artery disease.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Triglycerides | 1997 |
Effects of atorvastatin monotherapy and simvastatin plus cholestyramine on arterial endothelial function in patients with severe primary hypercholesterolaemia.
Topics: Adult; Anticholesteremic Agents; Arthralgia; Atorvastatin; Brachial Artery; Cholestyramine Resin; Drug Therapy, Combination; Endothelium, Vascular; Exanthema; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome; Ultrasonography | 1998 |
Compliance with and efficacy of treatment with pravastatin and cholestyramine: a randomized study on lipid-lowering in primary care.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Patient Compliance; Pravastatin; Primary Health Care; Sex Factors; Sweden; Treatment Outcome | 1998 |
Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study).
Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome; Triglycerides | 1998 |
[Lipid intervention and coronary heart disease in men less than 56 years of age. The Coronary Intervention Study: CIS].
Topics: Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Combined Modality Therapy; Coronary Angiography; Coronary Disease; Diet, Fat-Restricted; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Simvastatin | 1999 |
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Prospective Studies; Treatment Outcome | 1999 |
Achievement of target plasma cholesterol levels in hypercholesterolaemic patients being treated in general practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Family Practice; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hypercholesterolemia; Linear Models; Logistic Models; Male; Middle Aged; Pyrroles; Simvastatin; Treatment Outcome | 2000 |
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Nicotinic Acids | 1975 |
A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Liver Function Tests; Male; Middle Aged; Nicotinic Acids; Triglycerides | 1977 |
The effect of cholestyramine on serum lipids and platelet aggregation of hypercholesterolemic children (type II A) while on high linoleic acid diet.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Humans; Hypercholesterolemia; Linoleic Acids; Lipids; Placebos; Platelet Aggregation; Triglycerides | 1977 |
Effect of clofibrate and calcium in type II A hyperlipoproteinaemia.
Topics: Calcium; Calcium Carbonate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias | 1977 |
Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.
Topics: Adult; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feces; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Neomycin; Sitosterols | 1979 |
[Value of cholestyramine in the treatment of refractory diarrhea in infants and the newborn].
Topics: Acidosis; Bacteria; Bile Acids and Salts; Celiac Disease; Cholestyramine Resin; Clinical Trials as Topic; Constipation; Diarrhea, Infantile; Endotoxins; Female; Humans; Hypercholesterolemia; Infant; Infant, Newborn; Male; Poisoning | 1976 |
Treatment of hypercholesterolemia with Secholex. A long-term clinical trial and comparison with cholestyramine.
Topics: Acacia; Adult; Anion Exchange Resins; Cholesterol; Cholestyramine Resin; DEAE-Dextran; Dextrans; Dose-Response Relationship, Drug; Drug Combinations; Feces; Female; Humans; Hypercholesterolemia; Ion Exchange Resins; Male; Middle Aged; Steroids; Sterols; Triglycerides | 1976 |
Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum.
Topics: Adult; Cholesterol; Cholestyramine Resin; Dietary Fiber; Female; Galactans; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Mannans; Middle Aged; Plant Gums; Sterols | 1992 |
Treatment of primary hypercholesterolaemia with pravastatin: efficacy and safety over three years.
Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pravastatin; Safety; Treatment Outcome; Triglycerides | 1992 |
[Lovastatin in primary hypercholesterolemia. A Norwegian multicenter study].
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Triglycerides | 1992 |
Effects of long-term cholestyramine administration on vitamin D and parathormone levels in middle-aged men with hypercholesterolemia.
Topics: Calcium; Cholestyramine Resin; Humans; Hypercholesterolemia; Male; Middle Aged; Parathyroid Hormone; Regression Analysis; Time Factors; Vitamin D | 1992 |
Comparison between lovastatin and cholestyramine in the treatment of moderate to severe primary hypercholesterolaemia.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Triglycerides | 1992 |
The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
Topics: Cause of Death; Cholelithiasis; Cholestyramine Resin; Cohort Studies; Coronary Disease; Double-Blind Method; Follow-Up Studies; Humans; Hypercholesterolemia; Incidence; Male; Neoplasms; Primary Prevention; Survival Analysis | 1992 |
Combination therapy with lovastatin and guar gum versus lovastatin and cholestyramine in treatment of hypercholesterolemia.
Topics: Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; Blood Pressure; Body Weight; Cholestyramine Resin; Double-Blind Method; Drug Therapy, Combination; Female; Galactans; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipids; Lovastatin; Male; Mannans; Middle Aged; Plant Gums | 1991 |
Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lens, Crystalline; Lipids; Liver; Lovastatin; Male; Middle Aged; Simvastatin | 1991 |
[Pravastatin, cholestyramine and gemfibrozil in long-term therapy of primary hypercholesterolemia. An open randomized comparative study].
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Female; Gemfibrozil; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides | 1991 |
Comparative study of a microporous cholestyramine analogue (filicol) and gemfibrozil for treatment of severe primary hypercholesterolemia. Short- and long-term results.
Topics: Adult; Aged; Apolipoproteins; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Gemfibrozil; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Triglycerides | 1991 |
Comparison of the efficacy of Questran Light, a new formulation of cholestyramine powder, to regular Questran in maintaining lowered plasma cholesterol levels.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Energy Intake; Humans; Hypercholesterolemia; Male; Middle Aged; Powders | 1991 |
[Treatment of hypercholesterolemic patients of different age with simvastatin: 1-year study].
Topics: Adult; Age Factors; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Middle Aged; Simvastatin; Time Factors | 1991 |
HMG CoA reductase inhibitors as lipid-lowering agents: five years experience with lovastatin and an appraisal of simvastatin and pravastatin.
Topics: Adult; Aged; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Naphthalenes; Phenotype; Pravastatin; Simvastatin; Time Factors | 1990 |
Pharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemia.
Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Phospholipids; Pravastatin; Randomized Controlled Trials as Topic; Triglycerides | 1990 |
[Comparison of the effectiveness of the HMG-CoA-reductase inhibitors pravastatin versus colestyramine in hypercholesteremia].
Topics: Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Pravastatin; Triglycerides | 1990 |
Hydroxymethylglutaryl coenzyme A reductase inhibitors as monotherapy in the treatment of hypercholesterolemia.
Topics: Bezafibrate; Cholestyramine Resin; Double-Blind Method; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Lovastatin; Probucol; Randomized Controlled Trials as Topic; Simvastatin | 1990 |
Efficacy of a combined bezafibrate retard-colestyramine treatment in patients with hypercholesterolemia.
Topics: Bezafibrate; Cholestyramine Resin; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Male; Middle Aged; Randomized Controlled Trials as Topic | 1990 |
Comparison of simvastatin and cholestyramine in the treatment of primary hypercholesterolaemia.
Topics: Adult; Aged; Analysis of Variance; Anticholesteremic Agents; Australia; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides | 1990 |
Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Topics: Adult; Alanine Transaminase; Anticholesteremic Agents; Cataract; Cholesterol; Cholestyramine Resin; Creatine Kinase; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin; Triglycerides | 1990 |
Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Apoproteins; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Patient Compliance; Simvastatin; Time Factors | 1989 |
Effect of combined therapy with bezafibrate and cholestyramine on low-density lipoprotein metabolism in type IIa hypercholesterolemia.
Topics: Adult; Bezafibrate; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Middle Aged; Triglycerides | 1989 |
Simvastatin (MK 733): an effective treatment for hypercholesterolemia.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Random Allocation; Simvastatin | 1989 |
Simvastatin and cholestyramine in the long-term treatment of hypercholesterolaemia.
Topics: Adult; Aged; Alanine Transaminase; Anticholesteremic Agents; Cholestyramine Resin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Lovastatin; Male; Middle Aged; Random Allocation; Simvastatin; Time Factors | 1989 |
[Is hypolipemic treatment effective as a preventive measure?].
Topics: Adult; Arteriosclerosis; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipoproteinemias; International Cooperation; Male; Middle Aged | 1989 |
Comparison between low-dose simvastatin and cholestyramine in moderately severe hypercholesterolemia.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Administration Schedule; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Simvastatin | 1989 |
Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.
Topics: Adult; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Diet; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Probability; Regression Analysis | 1987 |
A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III.
Topics: Adult; Aged; Alkaline Phosphatase; Apolipoproteins; Cholesterol; Cholestyramine Resin; Creatine Kinase; Female; Humans; Hypercholesterolemia; Lipoproteins; Lovastatin; Male; Middle Aged; Random Allocation; Transaminases; Triglycerides | 1988 |
Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
Topics: Arteriosclerosis; Cholestyramine Resin; Clinical Trials as Topic; Combined Modality Therapy; Drug Therapy, Combination; Female; Femoral Artery; Humans; Hypercholesterolemia; Lipids; Male; Phenols; Placebos; Probucol; Random Allocation; Remission Induction; Research Design; Sweden | 1988 |
Review of lipid-lowering clinical trials in relation to observational epidemiologic studies.
Topics: Adolescent; Adult; Age Factors; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Random Allocation; Risk | 1987 |
Effect of bezafibrate and colestyramine in patients with primary hypercholesterolemia.
Topics: Bezafibrate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Lipoproteins, VLDL; Male; Middle Aged; Random Allocation; Triglycerides | 1987 |
Seasonal cholesterol cycles: the Lipid Research Clinics Coronary Primary Prevention Trial placebo group.
Topics: Adult; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Climate; Clinical Trials as Topic; Diet; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Primary Prevention; Random Allocation; Research Design; Seasons; Triglycerides; United States | 1987 |
Differentiated dosage of microporous colestyramine and its double-blind comparison with a placebo in hypercholesterolaemic patients.
Topics: Adult; Cholesterol; Cholestyramine Resin; Dosage Forms; Double-Blind Method; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 1987 |
Dietary and other correlates of changes in total and low density lipoprotein cholesterol in hypercholesterolemic men: the lipid research clinics coronary primary prevention trial.
Topics: Adult; Antihypertensive Agents; Blood Glucose; Body Weight; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Dietary Fats; Fats, Unsaturated; Humans; Hypercholesterolemia; Male; Middle Aged; Random Allocation; Smoking | 1986 |
High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Cholesterol, HDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Prognosis; Random Allocation; Risk | 1986 |
The Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Death, Sudden; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction | 1986 |
Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Topics: Adult; Aged; Blood Pressure; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Phenols; Probucol; Random Allocation; Triglycerides | 1986 |
Commentary on the published results of the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Combined Modality Therapy; Coronary Disease; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Random Allocation; Research Design; Statistics as Topic | 1985 |
The Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Topics: Adult; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Digestive System; Double-Blind Method; Humans; Hypercholesterolemia; Male; Middle Aged; Random Allocation; Risk | 1985 |
Effect of plant sterols on serum lipids and atherosclerosis.
Topics: Absorption; Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clinical Trials as Topic; Food; Humans; Hypercholesterolemia; Phytosterols; Risk; Sitosterols | 1985 |
Treatment of essential hyperlipidaemia.
Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Electrophoresis; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoproteins; Xanthomatosis | 1969 |
The effect of colestipol or cholestyramine on serum cholesterol and triglycerides in a long-term controlled study.
Topics: Adult; Aged; Blood Glucose; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Depression, Chemical; Ethers, Cyclic; Female; Humans; Hypercholesterolemia; Ion Exchange Resins; Male; Middle Aged; Placebos; Polyamines; Time Factors; Triglycerides | 1972 |
[Treatment of hypercholesteremia with cholestyramine].
Topics: Adult; Aged; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos | 1972 |
Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
Topics: Adult; Age Factors; Body Weight; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Lipoproteins; Male; Middle Aged; Obesity; Placebos; Sex Factors; Triglycerides; Xanthomatosis | 1973 |
[Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Diet; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipoproteins; Male; Middle Aged; Triglycerides | 1974 |
Effects and side-effects of treatment of hypercholesterolemia with cholestyramine and neomycin.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Clofibrate; Constipation; Depression, Chemical; Diarrhea; Drug Therapy, Combination; Dyspepsia; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Nausea; Neomycin | 1973 |
Hypercholesteremia. Treatment with cholestyramine, a bile acid sequestering resin.
Topics: Adult; Aged; Cholestyramine Resin; Clinical Trials as Topic; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 1967 |
Combined use of clofibrate and cholestyramine or DEAE sephadex in hypercholesterolaemia.
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Constipation; Dextrans; Drug Synergism; Humans; Hypercholesterolemia; Propionates | 1971 |
211 other study(ies) available for cholestyramine resin and Hypercholesterolemia
| Article | Year |
|---|---|
Adjusting for adherence in randomized trials when adherence is measured as a continuous variable: An application to the Lipid Research Clinics Coronary Primary Prevention Trial.
Topics: Adult; Anticholesteremic Agents; Bias; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Incidence; Intention to Treat Analysis; Lipids; Logistic Models; Male; Medication Adherence; Middle Aged; Primary Prevention; Randomized Controlled Trials as Topic | 2020 |
Cocoa powder extracts exhibits hypolipidemic potential in cholesterol-fed rats.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Biological Availability; Cacao; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Monitoring; Hypercholesterolemia; Lipid Metabolism; Male; Plant Extracts; Powders; Rats; Rats, Wistar; Treatment Outcome | 2012 |
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients.
Topics: Aged; Anticholesteremic Agents; Bezafibrate; Cholestenones; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Complement C4; Data Interpretation, Statistical; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Kinetics; Male; Middle Aged; Reference Standards; Simvastatin | 2008 |
Lipid-lowering effects of methanolic extract of Vernonia amygdalina leaves in rats fed on high cholesterol diet.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Diet; Hypercholesterolemia; Lipid Peroxidation; Lipids; Male; Phytotherapy; Plant Leaves; Rats; Rats, Wistar; Vernonia | 2008 |
Steam cooking significantly improves in vitro bile acid binding of collard greens, kale, mustard greens, broccoli, green bell pepper, and cabbage.
Topics: Anticholesteremic Agents; Bile Acids and Salts; Brassica; Capsicum; Cellulose; Cholestyramine Resin; Cooking; Dietary Fiber; Humans; Hypercholesterolemia; Phytotherapy; Spinacia oleracea; Vegetables | 2008 |
Nitroxide derivatives for imaging of hypercholesterolemia-induced kidney dysfunction and assessing the effectiveness of antilipidemic drugs.
Topics: Animals; Anticholesteremic Agents; Azetidines; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Contrast Media; Cyclic N-Oxides; Drug Monitoring; Ezetimibe; Gadolinium DTPA; Humans; Hypercholesterolemia; Kidney; Kinetics; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nitrogen Oxides; Pyrrolidines; Renal Insufficiency | 2011 |
LDL cholesterol lowering by bile acid malabsorption during inhibited synthesis and absorption of cholesterol in hypercholesterolemic coronary subjects.
Topics: Aged; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Artery Disease; Diet, Fat-Restricted; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Intestinal Absorption; Male; Simvastatin; Sitosterols; Treatment Outcome | 2002 |
Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins?
Topics: Anticholesteremic Agents; Atorvastatin; Baroreflex; Blood Pressure; Cholestyramine Resin; Heart Rate; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Norepinephrine; Pyrroles; Sympathomimetics | 2002 |
Lack of cholesterol-lowering effect of graded doses of cholestyramine in children with Alagille syndrome: a pilot study.
Topics: Alagille Syndrome; Anticholesteremic Agents; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Female; Humans; Hypercholesterolemia; Male; Pilot Projects; Triglycerides | 2003 |
The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine.
Topics: Bile Duct Diseases; Bile Ducts; Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia; Ion Exchange Resins; Liver Cirrhosis, Biliary; Pruritus | 1961 |
Hormonal hypercholesterolemia in the dog: influence of niacin, niacinamide, benzmalecene, and cholestyramine resin.
Topics: Animals; Cholestyramine Resin; Dogs; Hypercholesterolemia; Ion Exchange Resins; Maleates; Niacin; Niacinamide; Nicotinic Acids | 1963 |
Treatment of pruritus of obstructive jaundice with cholestyramine.
Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Ion Exchange Resins; Jaundice; Jaundice, Obstructive; Pruritus | 1963 |
METABOLIC CHANGES INDUCED IN ELDERLY PATIENTS WITH A CHOLESTEROL LOWERING RESIN, CHOLESTYRAMINE.
Topics: Aged; Anticholesteremic Agents; Blood Urea Nitrogen; Carbon Dioxide; Cholesterol; Cholestyramine Resin; Drug Therapy; Geriatrics; Humans; Hypercholesterolemia; Ion Exchange Resins; Lipoproteins; Metabolism; Toxicology; Urea; Urine | 1964 |
CHOLESTYRAMINE RESIN THERAPY FOR HYPERCHOLESTEREMIA: CLINICAL AND METABOLIC STUDIES.
Topics: Biomedical Research; Blood Chemical Analysis; Cholesterol; Cholestyramine Resin; Drug Therapy; Humans; Hypercholesterolemia; Ion Exchange Resins; Metabolism; Xanthomatosis | 1965 |
THE LONG TERM USE OF CHOLESTYRAMINE IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS.
Topics: Alkaline Phosphatase; Aspartate Aminotransferases; Bilirubin; Blood; Calcium; Cholesterol; Cholestyramine Resin; Drug Therapy; Humans; Hypercholesterolemia; Ion Exchange Resins; Liver Cirrhosis; Liver Cirrhosis, Biliary; Phosphorus; Prothrombin Time; Pruritus; Serum Albumin; Serum Globulins; Toxicology | 1965 |
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2004 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Coronary Disease; Ezetimibe; Fatty Acids, Omega-3; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Risk Factors; Treatment Outcome | 2004 |
Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
Topics: Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Lovastatin; Meta-Analysis as Topic; Pravastatin; Pyrroles; Risk Factors; Simvastatin; Spain | 2006 |
Roles of nuclear receptors in the up-regulation of hepatic cholesterol 7alpha-hydroxylase by cholestyramine in rats.
Topics: Animals; Anticholesteremic Agents; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Disease Models, Animal; Gene Expression; Hypercholesterolemia; Lipids; Liver; Male; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Hypolipidemic effect of Telfairia occidentalis (fluted pumpkin) in rats fed a cholesterol-rich diet.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Cholesterol, HDL; Cholestyramine Resin; Cucurbitaceae; Diet; Hypercholesterolemia; Hypolipidemic Agents; Male; Mitochondria, Liver; Phytotherapy; Plant Leaves; Rats; Rats, Wistar; Triglycerides | 2007 |
Bounds on direct effects in the presence of confounded intermediate variables.
Topics: Anticholesteremic Agents; Biometry; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Male; Programming, Linear; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
The biologic consequences of hypercholesteremia in man and its treatment.
Topics: Adult; Aged; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Diet Therapy; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 1967 |
Treatment of hypercholesteremia with cholestyramine, a bile acid sequestering resin.
Topics: Adult; Aged; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged | 1967 |
[Hepatitis caused by procetofen].
Topics: Chemical and Drug Induced Liver Injury; Cholestyramine Resin; Female; Fenofibrate; gamma-Glutamylcyclotransferase; Humans; Hypercholesterolemia; Middle Aged; Phosphoric Monoester Hydrolases; Propionates | 1980 |
Probucol with cholestyramine.
Topics: Cholestyramine Resin; Drug Synergism; Humans; Hypercholesterolemia; Phenols; Probucol | 1981 |
Partial ileal bypass for hypercholesterolaemia.
Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Ileum | 1982 |
The decrease in coronary heart disease mortality. Status and perspectives on the role of cholesterol.
Topics: Adrenergic beta-Antagonists; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Triglycerides | 1984 |
Effects of cholestyramine on low density lipoprotein binding sites on liver membranes from rabbits with endogenous hypercholesterolemia induced by a wheat starch-casein diet.
Topics: Animals; Caseins; Cell Membrane; Cholestyramine Resin; Dietary Carbohydrates; Dietary Proteins; Hypercholesterolemia; Kinetics; Lipoproteins, LDL; Liver; Male; Rabbits; Receptors, Cell Surface; Receptors, LDL | 1982 |
Catabolism of low density lipoproteins by perfused rabbit livers: cholestyramine promotes receptor-dependent hepatic catabolism of low density lipoproteins.
Topics: Animals; Cell Membrane; Cholesterol, Dietary; Cholestyramine Resin; Edetic Acid; Hypercholesterolemia; Kinetics; Lipoproteins, LDL; Liver; Male; Rabbits; Receptors, Cell Surface; Receptors, LDL | 1982 |
Management of hypercholesterolaemia and cholestyramine.
Topics: Age Factors; Aged; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Middle Aged | 1984 |
Time to treat cholesterol seriously.
Topics: Adult; Cholesterol; Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Male; Middle Aged | 1984 |
Relationship between metabolism and composition of low density lipoproteins in rabbits on semi-purified diet.
Topics: Animals; Apoproteins; Cholesterol, Dietary; Cholestyramine Resin; Hypercholesterolemia; Lipoproteins, LDL; Male; Rabbits | 1983 |
Therapy of familial and acquired hyperlipoproteinemia in children and adolescents.
Topics: Adolescent; Child; Child, Preschool; Cholesterol; Cholesterol, Dietary; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Infant; Infant Food; Lipoproteins, LDL; Male; Patient Compliance; Triglycerides | 1983 |
Diet, drugs, and plasma exchange in the treatment of hyperlipidemia in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Combined Modality Therapy; Coronary Disease; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Male; Plasma Exchange; Polyamines | 1983 |
LRC-CPP trial.
Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia | 1984 |
[Definition and treatment of hypercholesterolemia; consequences of the Lipid Research Clinics study].
Topics: Adult; Cholestyramine Resin; Coronary Disease; Diet; Health Education; Humans; Hypercholesterolemia; Male; Middle Aged | 1984 |
Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis.
Topics: Absorption; Adult; Arteriosclerosis; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Coronary Disease; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Lipid Metabolism; Lipoproteins; Male; Phytosterols; Squalene; Xanthomatosis | 1980 |
[Drug therapy of hypercholesterinemias (author's transl)].
Topics: Adult; Bezafibrate; Cholestyramine Resin; Clofibric Acid; Colestipol; Dextrothyroxine; Fenofibrate; Humans; Hypercholesterolemia; Neomycin; Nicotinic Acids; Sitosterols | 1980 |
Efficacy, tolerance, and safety of colestipol HCL as a hypocholesterolemic agent in hyperlipidemic patients with studies of its effect on gastrointestinal absorption.
Topics: Adult; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Male; Polyamines | 1981 |
The effect of compactin, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme-A reductase activity, on cholesterogenesis and serum cholesterol levels in rats and chicks.
Topics: Animals; Anticholesteremic Agents; Chickens; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, VLDL; Lovastatin; Male; Naphthalenes; Rats | 1980 |
Synergistic effects of probucol and cholestyramine to lower serum cholesterol.
Topics: Adult; Aged; Cholesterol; Cholestyramine Resin; Dietary Fats; Drug Synergism; Drug Therapy, Combination; Humans; Hypercholesterolemia; Male; Middle Aged; Phenols; Probucol | 1981 |
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemia.
Topics: Adult; Aged; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Pravastatin; Triglycerides | 1993 |
Serum retinol levels throughout 2 years of cholesterol-lowering therapy.
Topics: Adult; Cholestyramine Resin; Diet; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Middle Aged; Retinol-Binding Proteins; Vitamin A | 1995 |
The effect of poor compliance and treatment side effects on sample size requirements in randomized clinical trials.
Topics: Cholestyramine Resin; Drug-Related Side Effects and Adverse Reactions; Humans; Hypercholesterolemia; Randomized Controlled Trials as Topic; Sampling Studies; Treatment Refusal | 1994 |
Malabsorption of thyroid hormone with cholestyramine administration.
Topics: Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Goiter, Nodular; Humans; Hypercholesterolemia; Middle Aged; Thyrotropin; Thyroxine | 1994 |
Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients.
Topics: Acetylcholine; Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Angiography; Coronary Vessels; Endothelium, Vascular; Humans; Hypercholesterolemia; Male; Middle Aged; Nitroglycerin; Vasodilation | 1993 |
[Vasosan S--a cholestyramine in the treatment of hypercholesterolemia of various etiopathogenesis].
Topics: Adult; Apolipoproteins B; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Triglycerides | 1994 |
New guidelines for managing hypercholesterolemia. National Cholesterol Education Program.
Topics: Algorithms; Anticholesteremic Agents; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Niacin; Oxidoreductases; Risk Factors | 1993 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Probucol | 1993 |
Serum concentration of 7 alpha-hydroxycholesterol as an indicator of bile acid synthesis in humans.
Topics: Bile Acids and Salts; Cholestyramine Resin; Feces; Freezing; Gas Chromatography-Mass Spectrometry; Humans; Hydroxycholesterols; Hypercholesterolemia; Liver Cirrhosis; Male; Oxidation-Reduction; Reference Values; Reproducibility of Results; Sterols | 1995 |
Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in hamsters with dietary-induced hypercholesterolemia.
Topics: Animals; Anticholesteremic Agents; Bile Acids and Salts; Cathartics; Cholesterol, LDL; Cholestyramine Resin; Cricetinae; Drug Combinations; Hypercholesterolemia; Male; Mesocricetus; Psyllium | 1996 |
[Disorders of lipid metabolism--diagnosis and therapy in general practice. 4: Therapy of hypercholesterolemia--drug treatment].
Topics: Anion Exchange Resins; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia | 1996 |
[Effect of cholestyramine on angiopathies in cholesterol-fed mice and diabetic mice].
Topics: Animals; Anticholesteremic Agents; Cholesterol, Dietary; Cholestyramine Resin; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Hypercholesterolemia; Male; Mice; Mice, Inbred ICR; Pravastatin; Vascular Diseases; Vasodilation | 1995 |
Urinary excretion of mevalonic acid as an indicator of cholesterol synthesis.
Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Circadian Rhythm; Female; Humans; Hypercholesterolemia; Lovastatin; Male; Mevalonic Acid; Middle Aged; Pravastatin; Reproducibility of Results; Simvastatin; Xanthomatosis, Cerebrotendinous | 1996 |
[New markers of atherogenic risk: hemorrheological profile in children and adolescents with familial hypercholesterolemia].
Topics: Adolescent; Anticholesteremic Agents; Blood Viscosity; Child, Preschool; Cholestyramine Resin; Erythrocyte Aggregation; Female; Fibrinogen; Humans; Hypercholesterolemia; Male | 1996 |
Effects of an HMG-CoA reductase inhibitor, pravastatin, and bile sequestering resin, cholestyramine, on plasma plant sterol levels in hypercholesterolemic subjects.
Topics: Acyl Coenzyme A; Adult; Anticholesteremic Agents; Cholestyramine Resin; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Phytosterols; Pravastatin | 1995 |
Lipid-lowering drugs and mortality.
Topics: Cholestyramine Resin; Coronary Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Pravastatin; Treatment Outcome | 1997 |
Plasma cholesteryl ester transfer protein is lowered by treatment of hypercholesterolemia with cholestyramine.
Topics: Anticholesteremic Agents; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholestyramine Resin; Female; Glycoproteins; Humans; Hypercholesterolemia; Lipids; Male | 1997 |
Lack of left ventricular dysfunction associated with sustained exposure to hyperlipidemia following lung transplantation.
Topics: Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Echocardiography; Female; Follow-Up Studies; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypertriglyceridemia; Hypolipidemic Agents; Immunosuppressive Agents; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Lung Transplantation; Male; Middle Aged; Myocardial Ischemia; Probucol; Radionuclide Angiography; Retrospective Studies; Triglycerides; Ventricular Dysfunction, Left; Ventricular Function, Left | 1997 |
Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapy.
Topics: Adult; Apolipoproteins B; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, VLDL; Male; Middle Aged; Pyrazines | 1995 |
Studies of cholesterol and bile acid metabolism, and early atherogenesis in hamsters fed GT16-239, a novel bile acid sequestrant (BAS).
Topics: Allylamine; Animals; Anticholesteremic Agents; Aortic Diseases; Arteriosclerosis; Aryl Hydrocarbon Hydroxylases; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Cricetinae; Cytochrome P-450 Enzyme System; Feces; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Lipoproteins; Liver; Male; Mesocricetus; Polyamines; Steroid Hydroxylases | 1998 |
[Drug clinics. How I treat various metabolic diseases treated by a drug intervention that targets the intestine].
Topics: Acarbose; Anion Exchange Resins; Anti-Obesity Agents; Cholestyramine Resin; Diabetes Mellitus; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hypercholesterolemia; Hypoglycemia; Hypoglycemic Agents; Hypolipidemic Agents; Intestine, Small; Lactones; Lipase; Metabolic Diseases; Orlistat; Trisaccharides | 1998 |
Immunoadsorption and dextran sulfate cellulose LDL-apheresis for severe hypercholesterolemia: the Rogosin Institute experience 1982-1992.
Topics: Adult; Aged; Blood Component Removal; Child; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Dextran Sulfate; Humans; Hypercholesterolemia; Immunosorbent Techniques; Lovastatin; Middle Aged; Niacin; Pilot Projects | 1993 |
Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden.
Topics: Adult; Cholestyramine Resin; Coronary Disease; Cost Savings; Cost-Benefit Analysis; Health Care Costs; Humans; Hypercholesterolemia; Life Expectancy; Lovastatin; Male; Middle Aged; Multivariate Analysis; Sweden | 1992 |
Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses.
Topics: Animals; Antioxidants; Aorta; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Diet, Atherogenic; Fatty Acids; Female; Fetus; Hypercholesterolemia; Lipid Peroxidation; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rabbits; Remission Induction; Triglycerides; Vitamin E | 2000 |
Successful combination therapy--flunarizine, pentoxifylline, and cholestyramine--for spur cell anemia.
Topics: Adult; Anemia, Hemolytic; Anticholesteremic Agents; Calcium; Calcium Channel Blockers; Chelating Agents; Chenodeoxycholic Acid; Cholesterol; Cholestyramine Resin; Drug Eruptions; Drug Therapy, Combination; Erythrocyte Membrane; Flunarizine; Humans; Hyperbilirubinemia; Hypercholesterolemia; Liver Cirrhosis, Alcoholic; Male; Membrane Lipids; Pentoxifylline; Phospholipids | 2001 |
Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
Topics: Anticholesteremic Agents; Bezafibrate; Cholestyramine Resin; Clinical Trials as Topic; Clofibrate; Female; Gemfibrozil; Humans; Hypercholesterolemia; Lovastatin; Male; Myocardial Infarction; Pravastatin; Treatment Outcome | 1999 |
Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Aorta; Aortic Diseases; Arteriosclerosis; Cholestyramine Resin; Disease Progression; Female; Hypercholesterolemia; Linoleic Acid; Lipid Peroxidation; Malondialdehyde; Pregnancy; Rabbits; Vitamin E | 2001 |
Portacaval shunt in four patients with homozygous hypercholesterolaemia.
Topics: Adolescent; Adult; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fats; Female; Glucose; Homozygote; Humans; Hypercholesterolemia; Infant; Infant, Newborn; Male; Middle Aged; Nicotinic Acids; Parenteral Nutrition; Pedigree; Portacaval Shunt, Surgical; Preoperative Care; Protein Hydrolysates; Triglycerides | 1975 |
Dose-effect relation of cholestryamine in children and young adults with familial hypercholesterolaemia.
Topics: Administration, Oral; Adolescent; Adult; Child; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Folic Acid; Follow-Up Studies; Humans; Hypercholesterolemia; Lipoproteins, LDL; Triglycerides | 1977 |
Cholestyramine in hypercholesterolaemia.
Topics: Child; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia | 1977 |
3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human hair roots.
Topics: Abetalipoproteinemia; Adolescent; Adult; Alcohol Oxidoreductases; Animals; Carbon Radioisotopes; Child; Cholestyramine Resin; Circadian Rhythm; Coenzymes; Female; Fibroblasts; Genotype; Hair; Humans; Hypercholesterolemia; Lipoproteins, LDL; Liver; Male; Mevalonic Acid; Middle Aged; Rats; Tritium | 1975 |
Should hyperlipoproteinemia be treated in patients with coronary artery disease?
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Body Weight; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Nicotinic Acids; Resins, Plant; Triglycerides | 1975 |
Cholestyramine: an effective, twice-daily dosage regimen.
Topics: Adult; Cholesterol; Cholestyramine Resin; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Hypercholesterolemia; Lipoproteins, LDL; Middle Aged | 1976 |
Changes in plasma lipoproteins in subjects treated with the bile acid-sequestering resin polidexide (Secholex).
Topics: Adult; Anion Exchange Resins; Apoproteins; Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Male; Triglycerides | 1976 |
A study of the dose-effect relationship of cholestyramine in children with familial hypercholesterolemia.
Topics: Adolescent; Body Weight; Cholestyramine Resin; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Lipoproteins, LDL | 1977 |
Acute effects of cholestyramine on serum lipoprotein concentrations in type II hyperlipoproteinaemia.
Topics: Aged; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Triglycerides | 1978 |
Cholestyramine and ileal by-pass in the treatment of familial hypercholesterolaemia.
Topics: Adult; Bile Acids and Salts; Child; Cholesterol; Cholestyramine Resin; Feces; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ileum; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Steroids | 1977 |
Hyperlipidaemia, smoking and hypertension. The place of the hyperlipidaemias.
Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Coronary Disease; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Risk; Triglycerides | 1978 |
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemia.
Topics: Cholestyramine Resin; Clofibrate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Niceritrol; Nicotinic Acids; Triglycerides | 1975 |
The baboon as an experimental model in drug testing.
Topics: Animals; Antigen-Antibody Reactions; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Disease Models, Animal; Haplorhini; Hypercholesterolemia; Papio; Serum Albumin, Bovine | 1977 |
Drug management of hypercholesterolemia.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Humans; Hypercholesterolemia; Nicotinic Acids; Probucol; Sitosterols | 1979 |
Management of hyperlipidemia in diabetes.
Topics: Cholestyramine Resin; Clofibrate; Diabetes Complications; Diabetes Mellitus, Type 1; Humans; Hypercholesterolemia; Hyperlipidemias; Syndrome; Triglycerides | 1979 |
Hypercholesterolaemic arthropathy in primary biliary cirrhosis.
Topics: Arthritis; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Middle Aged | 1979 |
Use of diet and probucol.
Topics: Child; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Phenols; Probucol | 1979 |
A practical guide to hyperlipidaemic disorders.
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids | 1977 |
[Action of cholestyramine on blood lipids].
Topics: Adult; Cholestyramine Resin; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged | 1977 |
A cause of hypercholesterolemia in alloxan diabetic rat.
Topics: Animals; Bile; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Diabetes Mellitus, Experimental; Hypercholesterolemia; Intestine, Small; Liver; Male; Rats; Sterols | 1978 |
[A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Phospholipids; Polyamines | 1978 |
New microporous cholestyramine analog for treatment of hypercholesterolemia.
Topics: Adult; Aged; Cholestyramine Resin; Cholic Acids; Colestipol; Constipation; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Suspensions | 1978 |
[Questran].
Topics: Cholestyramine Resin; Humans; Hypercholesterolemia | 1978 |
[Resins in the treatment of hypercholesterolemia].
Topics: Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia; Triglycerides | 1978 |
Treatment of induced cholesteremia and atherosclerosis in rabbits with cholestyramine, niacin and taurine.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Hypercholesterolemia; Male; Nicotinic Acids; Rabbits; Taurine; Time Factors | 1975 |
Therapy of familial hypercholesterolemia in childhood: diet and cholestyramine resin for 24 to 36 months.
Topics: Adolescent; Child; Cholesterol; Cholestyramine Resin; Female; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Resins, Plant; Triglycerides | 1977 |
The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia.
Topics: Adolescent; Adult; Bile Acids and Salts; Child; Cholestyramine Resin; Feces; Female; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Male; Middle Aged; Steroids | 1977 |
Effects of cholestyramine on cholesterol balance parameters and hepatic HMG-CoA reductase and cholesterol-7-alpha-hydroxylase activities in swine.
Topics: Alcohol Oxidoreductases; Animals; Bile Acids and Salts; Body Weight; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Cholestyramine Resin; Diet; Feces; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Liver; Male; Microsomes, Liver; Steroid Hydroxylases; Steroids; Swine | 1977 |
[Tinnitus and lipid metabolism disorders. Value of early normolipemic treatment].
Topics: Anticholesteremic Agents; Blood Platelet Disorders; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Intracranial Arteriosclerosis; Intracranial Embolism and Thrombosis; Nicotinic Acids; Tinnitus | 1977 |
Treatment of hyperlipidemias in childhood.
Topics: Adolescent; Child; Child, Preschool; Cholestyramine Resin; Colestipol; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Triglycerides | 1977 |
Dextrothyroxine for lowering cholesterol.
Topics: Angina Pectoris; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Humans; Hypercholesterolemia; Hyperlipidemias; Myocardial Infarction; Nicotinic Acids | 1976 |
[Treatment of hyperlipidemia].
Topics: Adult; Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Neomycin; Nicotinic Acids | 1976 |
[Therapy of the chronic destructive, non-purulent cholangitis (primary biliary cirrhosis)].
Topics: Azathioprine; Calcium; Cholangitis; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Osteoporosis; Phenobarbital; Pruritus; Vitamin D | 1976 |
Immunodeficiency, xanthomas and obstructive liver disease.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Child; Cholestyramine Resin; Cholic Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Immunologic Deficiency Syndromes; Liver Diseases; Male; Phenobarbital; Pruritus; Xanthomatosis | 1976 |
Treatment of children with familial hypercholesterolaemia.
Topics: Adolescent; Celiac Disease; Child; Child, Preschool; Cholestyramine Resin; Clofibrate; Fatty Acids, Unsaturated; Female; Folic Acid Deficiency; Follow-Up Studies; Heterozygote; Humans; Hypercholesterolemia; Infant; Male; Phosphorus; Vitamin A; Vitamin E | 1975 |
Letter: Possible ineffective use of cholestyramine.
Topics: Cholestyramine Resin; Hypercholesterolemia | 1975 |
Cholesterol kinetic analysis in normal and cholesterol-fed rabbits; effects of saturated versus polyunsaturated fat and of cholestyramine.
Topics: Animals; Body Composition; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Cocos; Diet, Atherogenic; Dietary Fats; Fats, Unsaturated; Hypercholesterolemia; Hyperlipidemias; Kinetics; Male; Oils; Rabbits; Structure-Activity Relationship; Zea mays | 1975 |
The investigation and treatment of hyperlipidaemia in general practice.
Topics: Adult; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Diet, Reducing; Family Practice; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged | 1975 |
Effect of combined clofibrate-cholestyramine treatment on serum and tissue cholesterol pools and on cholesterol synthesis in hypercholesterolemic swine.
Topics: Animals; Bile; Body Composition; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Diet; Feces; Hypercholesterolemia; Male; Swine; Time Factors | 1975 |
The effect of cholestyramine on intestinal absorption.
Topics: Animals; Blood Proteins; Calcium; Child; Child, Preschool; Cholestyramine Resin; Dietary Fats; Erythrocytes; Feces; Folic Acid; Folic Acid Deficiency; Growth; Humans; Hypercholesterolemia; Infant; Intestinal Absorption; Iron; Phosphorus; Prothrombin Time; Rats; Vitamin A; Vitamin B 12; Vitamin E | 1975 |
[Mechanism of action of drugs affecting lipid metabolism].
Topics: Animals; Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Lipid Mobilization; Nicotinic Acids | 1975 |
Treatment of hypercholesterolaemia in children.
Topics: Child; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lovastatin; Male | 1992 |
Short- and long-term effects of lovastatin and pravastatin alone and in combination with cholestyramine on serum lipids, lipoproteins and apolipoproteins in primary hypercholesterolaemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Lovastatin; Male; Middle Aged; Pravastatin; Time Factors; Triglycerides | 1992 |
Statistical validation of intermediate endpoints for chronic diseases.
Topics: Biomarkers; Cholestyramine Resin; Chronic Disease; Coronary Disease; Humans; Hypercholesterolemia; Incidence; Male; Middle Aged; Models, Statistical; Probability; Prospective Studies; Risk Factors | 1992 |
Hypolipidemic drugs reduce lipoprotein susceptibility to undergo lipid peroxidation: in vitro and ex vivo studies.
Topics: Adult; Animals; Bezafibrate; Cells, Cultured; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Esterification; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipid Peroxidation; Lipoproteins, LDL; Macrophages; Male; Malondialdehyde; Mice; Middle Aged; Pravastatin; Vitamin E | 1992 |
Primary prevention of coronary heart disease with drug therapy. Safety and total mortality issues.
Topics: Adult; Cholestyramine Resin; Coronary Disease; Follow-Up Studies; Humans; Hypercholesterolemia; Male; Primary Prevention; Survival Rate | 1992 |
Effects of cholestyramine and acipimox on subfractions of plasma low density lipoprotein. Studies in normolipidaemic and hypercholesterolaemic subjects.
Topics: Adult; Centrifugation, Density Gradient; Cholestyramine Resin; Drug Therapy, Combination; Electrophoresis; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Male; Middle Aged; Pyrazines; Reference Values | 1992 |
[Cholesterol level 200: prevention and therapy. Specialty Press Conference. Frankfurt, 8 November 1990].
Topics: Cholesterol; Cholestyramine Resin; Humans; Hypercholesterolemia | 1991 |
Urethral calculi caused by cholestyramine.
Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Male; Middle Aged; Urethra; Urinary Calculi | 1991 |
[The cholesterol question. Disinformed information].
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Coronary Disease; Gemfibrozil; Humans; Hypercholesterolemia; Pilot Projects; Risk Factors | 1991 |
Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein B-100; Apolipoproteins B; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Heterozygote; Humans; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Phenotype; Simvastatin; Triglycerides | 1991 |
[Cost-effectiveness of lowering of blood cholesterol using simvastatin and cholestyramine].
Topics: Adult; Age Factors; Anticholesteremic Agents; Cholestyramine Resin; Cost-Benefit Analysis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Netherlands; Sex Factors; Simvastatin | 1991 |
Acceptability of cholestyramine and colestipol formulations in three common vehicles.
Topics: Adult; Chemistry, Pharmaceutical; Cholestyramine Resin; Colestipol; Double-Blind Method; Evaluation Studies as Topic; Female; Humans; Hypercholesterolemia; Male; Prospective Studies; Random Allocation; Taste | 1991 |
Low density lipoprotein receptor levels and the response to dietary and pharmacological intervention in polygenic hypercholesterolemia.
Topics: Adult; Apolipoproteins B; Bezafibrate; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Humans; Hypercholesterolemia; Lymphocytes; Middle Aged; Receptors, LDL | 1991 |
Treatment guidelines for hypercholesterolemia.
Topics: Cholestyramine Resin; Humans; Hypercholesterolemia; Nursing, Practical; Patient Compliance; Patient Education as Topic | 1991 |
Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
Topics: Adult; Aged; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoprotein C-III; Apolipoproteins; Apolipoproteins A; Apolipoproteins B; Apolipoproteins C; Apolipoproteins E; Bile Acids and Salts; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Evaluation; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipid Metabolism; Lipoproteins; Male; Middle Aged; Naphthalenes; Pravastatin; Random Allocation; Triglycerides | 1990 |
[Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
Topics: Adolescent; Adult; Apolipoproteins; Cholesterol; Cholestyramine Resin; Drug Evaluation; Drug Tolerance; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Time Factors; Triglycerides | 1990 |
Response to diet and cholestyramine in a patient with sitosterolemia.
Topics: Arteriosclerosis; Child; Cholestyramine Resin; Combined Modality Therapy; Humans; Hypercholesterolemia; Lipid Metabolism, Inborn Errors; Male; Sitosterols; Xanthomatosis | 1990 |
[Experimental and clinical study of Vasosan P, a new form of pectin-enriched cholestyramine].
Topics: Animals; Cholesterol; Cholestyramine Resin; Guinea Pigs; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipid Metabolism; Lipids; Lipoproteins, VLDL; Liver; Rats; Triglycerides | 1990 |
Therapy for hypercholesterolemia; standardization of cholesterol measurements.
Topics: Cholesterol; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Hypercholesterolemia; Reference Standards; Thyroid Function Tests | 1990 |
Therapeutic priorities of Canadian internists.
Topics: Attitude of Health Personnel; Canada; Cardiovascular Diseases; Cholestyramine Resin; Humans; Hypercholesterolemia; Internal Medicine; Isoniazid; Tuberculosis | 1990 |
Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.
Topics: Animals; Cholesterol; Cholestyramine Resin; Diet; Disease Models, Animal; Glomerular Filtration Rate; Hypercholesterolemia; Kidney Glomerulus; Male; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides | 1990 |
[Effects of low-dose cholestyramine in long-term therapy of hypercholesterolemia].
Topics: Adolescent; Adult; Aged; Cholesterol, HDL; Cholestyramine Resin; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Time Factors | 1990 |
Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro.
Topics: Aged; Cells, Cultured; Cholesterol; Cholestyramine Resin; Fatty Acids; Female; Food, Formulated; Humans; Hypercholesterolemia; Lipoproteins, LDL; Macrophages; Male; Middle Aged; Oxidation-Reduction; Phenols; Probucol; Receptors, LDL | 1990 |
Effect of cholestyramine in early weaning on later response to serum and fecal steroid levels and cholesterol 7 alpha-hydroxylase activity to high-cholesterol diet in ExHC rats.
Topics: Animals; Bile Acids and Salts; Chenodeoxycholic Acid; Cholesterol 7-alpha-Hydroxylase; Cholesterol, Dietary; Cholestyramine Resin; Cholic Acid; Cholic Acids; Deoxycholic Acid; Feces; Hypercholesterolemia; Lithocholic Acid; Liver; Male; Rats; Rats, Inbred Strains; Steroid Hydroxylases; Weaning | 1990 |
Comparison of hypocholesterolemic activities of the bile acid sequestrants cholestyramine and colestipol hydrochloride in cholesterol fed SEA quail.
Topics: Animals; Arteriosclerosis; Bile Acids and Salts; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Colestipol; Coturnix; Diet, Atherogenic; Disease Models, Animal; Hypercholesterolemia; Male; Polyamines; Therapeutic Equivalency | 1990 |
Lovastatin reduces postprandial lipoprotein levels in hypercholesterolaemic patients with mild hypertriglyceridaemia.
Topics: Adult; Aged; Cholesterol, LDL; Cholesterol, VLDL; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Lipoproteins; Lovastatin; Male; Middle Aged; Triglycerides | 1989 |
Controlling cholesterol with drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Drug Therapy, Combination; Humans; Hypercholesterolemia; Lovastatin; Niacin | 1989 |
[Diets and drugs to lower blood cholesterol].
Topics: Cholesterol; Cholestyramine Resin; Dietary Fats; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia | 1989 |
The purity of cholestyramine resin.
Topics: Adult; Child; Cholestyramine Resin; Drug Contamination; Humans; Hypercholesterolemia; Male; Middle Aged | 1989 |
Effects of doxazosin on diet-induced hypercholesterolemia in C57BR/cdJ mice.
Topics: Adrenergic alpha-Antagonists; Animals; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Disease Models, Animal; Doxazosin; Female; Hypercholesterolemia; Lipoproteins; Male; Mice; Mice, Inbred Strains; Prazosin | 1987 |
[Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lovastatin; Male; Middle Aged; Simvastatin | 1989 |
[Physiology and pathophysiology of lipoprotein metabolism--relation to hyperlipemias and arteriosclerosis].
Topics: Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Enterohepatic Circulation; Homeostasis; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipoproteins; Liver; Muscle, Smooth, Vascular; Receptors, Cell Surface; Receptors, Lipoprotein; Triglycerides | 1985 |
Hypercholesterolemia: new values, new strategies.
Topics: Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Colestipol; Coronary Disease; Energy Intake; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Niacin | 1986 |
Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine.
Topics: Adult; Aged; Cholestyramine Resin; Coronary Disease; Cost-Benefit Analysis; Humans; Hypercholesterolemia; Life Expectancy; Male; Middle Aged | 1987 |
Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Coronary Disease; Cost-Benefit Analysis; Edible Grain; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Office Visits; Polyamines; Smoking | 1988 |
Intestinal HMG-CoA reductase activity is low in hypercholesterolemic patients and is further decreased with lovastatin therapy.
Topics: Bile; Cholestyramine Resin; Female; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Intestinal Mucosa; Jejunum; Lovastatin; Male; Middle Aged | 1988 |
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel.
Topics: Adult; Aged; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Coronary Disease; Dietary Fats; Female; Gemfibrozil; Humans; Hydroxymethylglutaryl CoA Reductases; Hypercholesterolemia; Male; Middle Aged; Niacin; Patient Compliance; Pentanoic Acids; Probucol; Risk Factors | 1988 |
Correlative studies of the hypocholesterolemic effect of a highly activated charcoal.
Topics: Animals; Anticholesteremic Agents; Charcoal; Cholestyramine Resin; Deoxycholic Acid; Hypercholesterolemia; In Vitro Techniques; Rabbits | 1987 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Hypertriglyceridemia: a contraindication to the use of bile acid binding resins.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Colestipol; Drug Evaluation; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Polyamines; Time Factors; Triglycerides | 1987 |
Comparison of six pharmacologic regimens for hypercholesterolemia.
Topics: Adult; Aged; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Retrospective Studies | 1987 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin | 1987 |
Paediatric guidelines for lipid reduction.
Topics: Child; Child, Preschool; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Male; Reference Values | 1987 |
[Cholesterol consensus in The Netherlands].
Topics: Cholesterol, Dietary; Cholestyramine Resin; Humans; Hypercholesterolemia | 1987 |
Lovastatin: cholesterol-lowering agent.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Humans; Hypercholesterolemia; Lovastatin; Probucol | 1987 |
The effect of cholestyramine on apolipoproteins in cholesterol-fed rabbits.
Topics: Animals; Apolipoproteins; Apolipoproteins B; Apolipoproteins E; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Electrophoresis, Polyacrylamide Gel; Hypercholesterolemia; Male; Rabbits | 1986 |
Interactions of the major risk factors for coronary heart disease.
Topics: Age Factors; Animals; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Diet, Reducing; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemias; Hypertension; Male; Physical Exertion; Risk; Smoking; Sodium Chloride | 1986 |
Preventing myocardial infarction: cholestyramine (Questran) and other hypolipidemics.
Topics: Cholestyramine Resin; Constipation; Humans; Hypercholesterolemia; Hypolipidemic Agents; Kinetics; Myocardial Infarction; Nurse Practitioners; Patient Education as Topic | 1986 |
Cholestyramine treatment during pregnancy in the rat results in hypercholesterolemia.
Topics: Animals; Bile Acids and Salts; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Cholestyramine Resin; Feces; Female; Gestational Age; Hypercholesterolemia; Liver; Pregnancy; Pregnancy Complications; Rats; Rats, Inbred Strains; Steroids | 1985 |
Treatment of young rats with cholestyramine or a hypercholesterolemic diet does not influence the response of serum cholesterol to dietary cholesterol in later life.
Topics: Age Factors; Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Female; Hypercholesterolemia; Liver; Rats; Rats, Inbred Strains | 1985 |
[Hyperlipidemia and coronary disease].
Topics: Adult; Cholestyramine Resin; Coronary Disease; Europe; Humans; Hypercholesterolemia; Hyperlipidemias; Japan; Male; Middle Aged; Risk; United States | 1985 |
Portacaval shunt in hyperlipoproteinaemia.
Topics: Acute Disease; Angina Pectoris; Aortic Valve Stenosis; Biopsy; Child; Child, Preschool; Cholestyramine Resin; Diet Therapy; Female; Follow-Up Studies; Heart Failure; Homozygote; Humans; Hypercholesterolemia; Infant; Lipoproteins; Lipoproteins, LDL; Liver; Microscopy, Electron; Myocardial Infarction; Portacaval Shunt, Surgical; Triglycerides; Xanthogranuloma, Juvenile | 1973 |
Letter: Portacaval shunt in familial hypercholesterolaemia.
Topics: Cholestyramine Resin; Homozygote; Humans; Hypercholesterolemia; Nicotinic Acids; Portacaval Shunt, Surgical | 1974 |
Experiences with the homozygous cases of familial hypercholesterolemia. A report of 52 patients.
Topics: Adolescent; Adult; Blood Protein Disorders; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Female; Homozygote; Humans; Hypercholesterolemia; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinic Acids; Xanthomatosis | 1973 |
[On the treatment of hyperlipoproteinaemia type II with cholestyramine (author's transl)].
Topics: Adult; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male | 1973 |
Homozygous type II hyperlipoproteinemia treatment. Partial ileal bypass in two children.
Topics: Adult; Child; Cholesterol; Cholestyramine Resin; Diet; Female; Follow-Up Studies; Homozygote; Humans; Hypercholesterolemia; Ileum; Lipoproteins, LDL; Male; Pedigree; Phenotype; Resins, Plant; Xanthogranuloma, Juvenile | 1974 |
Hyperlipidemia and coronary artery disease. Prinicples of diet and drug treatment.
Topics: Amino Alcohols; Arteriosclerosis; Carbohydrates; Cholestyramine Resin; Coronary Disease; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Polymers; Triglycerides | 1974 |
Cholestyramine for elevated serum cholesterol.
Topics: Blood Protein Disorders; Celiac Disease; Cholestyramine Resin; Constipation; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipoproteins, LDL; Triglycerides | 1974 |
Familial type II hyperlipoproteinaemia. Clinical features and results of treatment in children and young adults.
Topics: Adolescent; Adult; Age Factors; Blood Protein Electrophoresis; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diet Therapy; Female; Homozygote; Humans; Hypercholesterolemia; Infant; Infant, Newborn; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Pedigree | 1974 |
Plasma vitamin A and E levels in children with familial type II hyperlipoproteinemia during therapy with diet and cholestyramine resin.
Topics: Adolescent; Adult; Blood Protein Disorders; Child; Child, Preschool; Cholestyramine Resin; Diet Therapy; Dietary Fats; Follow-Up Studies; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Lipoproteins, LDL; Resins, Plant; Vitamin A; Vitamin E | 1974 |
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Nicotinic Acids; Phenformin | 1974 |
Pseudohomozygous type II hyperlipoproteinemia.
Topics: Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diagnosis, Differential; Female; Humans; Hypercholesterolemia; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Nicotinic Acids; Pedigree; Triglycerides | 1974 |
Hypercholesterolemia and hypertriglyceridemia in children.
Topics: Adolescent; Adult; Arteriosclerosis; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Diet, Reducing; Humans; Hypercholesterolemia; Hyperlipidemias; Infant; Infant, Newborn; Lipids; Lipoproteins; Myocardial Infarction; Phenotype; Triglycerides | 1974 |
An effective treatment of hypercholesterolaemia. Use of a combination of a bile acid sequestrant and clofibrate.
Topics: Chlorides; Cholestyramine Resin; Clofibrate; Drug Synergism; Humans; Hypercholesterolemia; Ion Exchange Resins; Long-Term Care | 1972 |
Physiologic and clinical significance of ileal resection.
Topics: Bile Acids and Salts; Biotransformation; Celiac Disease; Cholelithiasis; Cholestyramine Resin; Diarrhea; Humans; Hypercholesterolemia; Ileum; Intestinal Diseases; Kidney Calculi; Lipid Metabolism; Malabsorption Syndromes; Obesity; Postoperative Complications; Vitamin B 12; Water-Electrolyte Balance | 1972 |
The combined use of clofibrate and anion exchange in the treatment of hypercholesterolemia.
Topics: Anion Exchange Resins; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therapy; Dietary Fats; Diethylamines; Drug Synergism; Fatty Acids, Unsaturated; Humans; Hypercholesterolemia; Ion Exchange Resins; Liver; Models, Biological; Time Factors; Triglycerides | 1972 |
An effective treatment of hypercholesterolaemia using a combination of Secholex and clofibrate.
Topics: Anticholesteremic Agents; Cholesterol; Cholestyramine Resin; Clofibrate; Dextrans; Drug Synergism; Ethylamines; Humans; Hypercholesterolemia; Ion Exchange Resins; Lipoproteins; Time Factors; Triglycerides | 1973 |
[Hypolipemic agents].
Topics: Androgens; Biological Transport; Butyrates; Cholestyramine Resin; Clofibrate; Estrogens; Fatty Acids, Nonesterified; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Absorption; Lipid Metabolism; Lipids; Neomycin; Nicotinic Acids; Thyroid Hormones; Triglycerides | 1973 |
[The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
Topics: Adult; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Coronary Disease; Electrophoresis, Polyacrylamide Gel; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipid Mobilization; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Phospholipids; Sitosterols; Triglycerides | 1973 |
Restraint of cholesterol accumulation in tissue pools associated with drastic short-term lowering of serum cholesterol levels by clofibrate or cholestyramine in hypercholesterolemic swine.
Topics: Animals; Bile Acids and Salts; Body Weight; Carbon Radioisotopes; Cholesterol; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Feces; Hypercholesterolemia; Intestines; Male; Swine | 1974 |
Effects of an anion exchange resin (cholestyramine) on atherogenesis in rhesus monkeys.
Topics: Animals; Arteriosclerosis; Cholestyramine Resin; Diet, Atherogenic; Haplorhini; Hypercholesterolemia; Iodine Isotopes; Time Factors | 1969 |
Comparison of the protective effects of cholestyramine and ileal bypass in rhesus monkeys on an atherogenic regimen.
Topics: Animals; Arteriosclerosis; Cholestyramine Resin; Diet, Atherogenic; Haplorhini; Hypercholesterolemia; Ileum; Methods | 1969 |
Symposium on arteriosclerotic heart disease. Medical management of angina pectoris.
Topics: Acute Disease; Angina Pectoris; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Diet Therapy; Exercise Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Neomycin; Nicotinic Acids; Nitrates; Stress, Physiological; Thyroxine; Triglycerides | 1972 |
Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidemia.
Topics: Adult; Aged; Bile; Bile Acids and Salts; Carbon Isotopes; Child; Cholesterol; Cholestyramine Resin; Clofibrate; Dietary Fats; Feces; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Intestinal Mucosa; Male; Middle Aged; Steroids; Triglycerides; Xanthomatosis | 1972 |
[Therapy of primary hyperlipidemias].
Topics: Cholestyramine Resin; Clofibrate; Diet Therapy; Heparin; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids | 1972 |
Drug treatment of hyperlipidemia.
Topics: Cholestyramine Resin; Clofibrate; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Triglycerides | 1972 |
[Hypercholesterinemia: treatment with Colestyramin].
Topics: Bile Acids and Salts; Binding Sites; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Iron; Male; Middle Aged; Water-Electrolyte Balance | 1972 |
Serum lipid precursors of coronary heart disease.
Topics: Adult; Aged; Arteriosclerosis; Blood Protein Disorders; Body Weight; Cholesterol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coronary Disease; Diet Therapy; Epidemiologic Methods; Female; Humans; Hypercholesterolemia; Lipids; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Phospholipids; Prognosis; Sex Factors; Thyroxine; Triglycerides | 1971 |
Classification of hyperlipidaemias.
Topics: Carbohydrate Metabolism; Cholestyramine Resin; Chylomicrons; Clofibrate; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Metabolic Clearance Rate; Neomycin; Nicotinic Acids; Obesity; Oxymetholone; Triglycerides | 1971 |
Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions.
Topics: Carbon Isotopes; Cholesterol; Cholestyramine Resin; Chromatography, Gas; Fasting; Feces; Humans; Hypercholesterolemia; Hyperlipidemias; Ileum; Lipoproteins; Obesity; Steroids; Sterols; Triglycerides; Tritium; Ultracentrifugation | 1971 |
Cholesterol metabolism in patients with coronary heart disease.
Topics: Adult; Bile Acids and Salts; Body Weight; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Coronary Disease; Electrocardiography; Feces; Female; Glucose Tolerance Test; Glycerides; Humans; Hypercholesterolemia; Hyperlipidemias; Lipids; Male; Middle Aged; Sterols; Triglycerides; Tritium | 1971 |
[Diagnosis and therapy of familial hyper- -lipoproteinemia (familial hypercholesterolemia or familial hyperlipoproteinemia of type II)].
Topics: Adolescent; Cholestyramine Resin; Clofibrate; Dextrans; Diet Therapy; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Thyroid Hormones | 1971 |
Control of biochemical precursors of coronary heart disease.
Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diabetes Mellitus; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Triglycerides | 1969 |
The metabolism of cholesterol in two hypercholesterolaemic patients treated with cholestyramine.
Topics: Adolescent; Adult; Bile Acids and Salts; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Feces; Female; Humans; Hypercholesterolemia; Injections, Intravenous; Male; Skin; Skin Manifestations; Steroids | 1969 |
[Drug therapy of hyperlipemia. Role of drugs at the disposition of general practitioners].
Topics: Cholestyramine Resin; Clofibrate; Estrogens; Family Practice; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Sterols; Thyroxine | 1970 |
Treatment of hyperlipidemic states.
Topics: Adult; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Coronary Disease; Dextrothyroxine; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Male; Middle Aged; Nicotinic Acids; Thyroid Hormones; Thyroxine; Triglycerides | 1970 |
Detection of changes in human cholesterol metabolism.
Topics: Bile Acids and Salts; Carbon Isotopes; Cholestanes; Cholesterol; Cholestyramine Resin; Deuterium; Fasting; Feces; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Malabsorption Syndromes; Male; Obesity; Sex Factors; Sterols; Triglycerides; Tritium | 1970 |
Diet and drug therapy for hyperlipoproteinemia.
Topics: Anticholesteremic Agents; Body Weight; Cholestyramine Resin; Clofibrate; Diet Therapy; Dietary Carbohydrates; Dietary Fats; Dietary Proteins; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Propionates; Thyroxine; Triglycerides | 1971 |
[Therapy of primary hyperlipemia].
Topics: Anticholesteremic Agents; Blood Protein Disorders; Cholestyramine Resin; Clofibrate; Diet, Reducing; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Nicotinic Acids | 1971 |
Control of diarrhea by cholestyramine administration.
Topics: Adolescent; Adult; Bile Acids and Salts; Biological Transport; Cholestyramine Resin; Colostomy; Diarrhea; Female; Gastrointestinal Motility; Humans; Hypercholesterolemia; Ileum; Intestinal Absorption; Male | 1968 |
Cholestyramine and hypercholesterolaemia.
Topics: Cholestyramine Resin; Humans; Hypercholesterolemia | 1968 |
Treatment of hypercholesterolemia. Combined dietary, surgical, and bile salt-binding resin therapy.
Topics: Adolescent; Adult; Cecum; Cholesterol; Cholestyramine Resin; Diet Therapy; Humans; Hypercholesterolemia; Ileum; Middle Aged | 1968 |
Effect of cholestyramine on the fecal excretion of intravenously administered cholesterol-4-14C and its degradation products in a hypercholesterolemic patient.
Topics: Bile Acids and Salts; Carbon Isotopes; Cholesterol; Cholestyramine Resin; Feces; Humans; Hypercholesterolemia; Injections, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Sterols | 1968 |
Hypolipidemic effect of polyvinylpyrrolidone in man.
Topics: Adult; Blood Glucose; Blood Pressure; Blood Proteins; Body Weight; Cholesterol; Cholestyramine Resin; Dextrans; Female; Follow-Up Studies; Hematocrit; Humans; Hypercholesterolemia; Hyperlipidemias; Infusions, Parenteral; Isotonic Solutions; Male; Middle Aged; Plasma Substitutes; Plasma Volume; Potassium; Povidone; Sodium; Triglycerides | 1968 |
Response of hyperlipoproteinemia to cholestyramine resin.
Topics: Adult; Blood Protein Electrophoresis; Cholesterol; Cholestyramine Resin; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Male; Middle Aged; Triglycerides | 1968 |
Cholestyramine.
Topics: Biliary Tract Diseases; Cholestyramine Resin; Diarrhea; Humans; Hypercholesterolemia; Pruritus | 1968 |
[Therapy of primary hyperlipemias].
Topics: Androsterone; Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Diet Therapy; Glycerides; Humans; Hypercholesterolemia; Hyperlipidemias; Nicotinic Acids; Smoking | 1969 |
New drugs for the treatment of hypercholesterolemia.
Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Dextrothyroxine; Humans; Hypercholesterolemia | 1969 |
[Basic treatment of coronary atherosclerosis].
Topics: Activities of Daily Living; Angina Pectoris; Anticoagulants; Cholesterol; Cholestyramine Resin; Coronary Angiography; Coronary Disease; Diet, Atherogenic; Diet, Diabetic; Diet, Reducing; Dietary Carbohydrates; Dietary Fats; Fats, Unsaturated; Female; Glucose Tolerance Test; Humans; Hypercholesterolemia; Hyperlipidemias; Hypertension; Lipids; Male; Nicotinic Acids; Smoking; Triglycerides; Uric Acid | 1969 |
Treatment of hypercholesteremia and hypertriglyceridemia.
Topics: Anticholesteremic Agents; Butyrates; Cholestyramine Resin; Dextrothyroxine; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides | 1969 |
Treatment of hypercholesteremia and hypertriglyceridemia.
Topics: Cholestyramine Resin; Diet Therapy; Humans; Hypercholesterolemia; Hyperlipidemias; Triglycerides | 1969 |
The effect of hypocholesteremic agents on the skin.
Topics: Acanthosis Nigricans; Alopecia; Anticholesteremic Agents; Arteriosclerosis; Cataract; Cholestyramine Resin; Hair; Humans; Hypercholesterolemia; Ichthyosis; Pruritus; Psoriasis; Skin Diseases; Xanthomatosis | 1966 |